TCBI 10-Q Quarterly Report March 31, 2025 | Alphaminr
TEXAS CAPITAL BANCSHARES INC/TX

TCBI 10-Q Quarter ended March 31, 2025

TEXAS CAPITAL BANCSHARES INC/TX
10-Ks and 10-Qs
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
tcbi-20250331
TEXAS CAPITAL BANCSHARES INC/TX 0001077428 12/31 2025 Q1 false Insider Trading Adopted Insider Trading Adopted Insider Trading Terminated Insider Trading Terminated http://fasb.org/us-gaap/2025#AccumulatedOtherComprehensiveIncomeLossNetOfTax http://fasb.org/us-gaap/2025#AccumulatedOtherComprehensiveIncomeLossNetOfTax http://fasb.org/us-gaap/2025#AccumulatedOtherComprehensiveIncomeLossNetOfTax http://fasb.org/us-gaap/2025#AccumulatedOtherComprehensiveIncomeLossNetOfTax http://fasb.org/us-gaap/2025#NoninterestIncomeOther http://fasb.org/us-gaap/2025#NoninterestIncomeOther http://fasb.org/us-gaap/2025#NoninterestIncomeOther http://fasb.org/us-gaap/2025#NoninterestIncomeOther http://fasb.org/us-gaap/2025#OtherAssets http://fasb.org/us-gaap/2025#OtherLiabilities http://fasb.org/us-gaap/2025#OtherAssets http://fasb.org/us-gaap/2025#OtherLiabilities xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure tcbi:security tcbi:instrument 0001077428 2025-01-01 2025-03-31 0001077428 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001077428 us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-03-31 0001077428 2025-04-15 0001077428 2025-03-31 0001077428 2024-12-31 0001077428 2024-01-01 2024-03-31 0001077428 us-gaap:PreferredStockMember 2023-12-31 0001077428 us-gaap:CommonStockMember 2023-12-31 0001077428 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001077428 us-gaap:RetainedEarningsMember 2023-12-31 0001077428 us-gaap:TreasuryStockCommonMember 2023-12-31 0001077428 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001077428 2023-12-31 0001077428 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001077428 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001077428 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001077428 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001077428 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0001077428 us-gaap:PreferredStockMember 2024-03-31 0001077428 us-gaap:CommonStockMember 2024-03-31 0001077428 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001077428 us-gaap:RetainedEarningsMember 2024-03-31 0001077428 us-gaap:TreasuryStockCommonMember 2024-03-31 0001077428 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001077428 2024-03-31 0001077428 us-gaap:PreferredStockMember 2024-12-31 0001077428 us-gaap:CommonStockMember 2024-12-31 0001077428 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001077428 us-gaap:RetainedEarningsMember 2024-12-31 0001077428 us-gaap:TreasuryStockCommonMember 2024-12-31 0001077428 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001077428 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001077428 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001077428 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001077428 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001077428 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0001077428 us-gaap:PreferredStockMember 2025-03-31 0001077428 us-gaap:CommonStockMember 2025-03-31 0001077428 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001077428 us-gaap:RetainedEarningsMember 2025-03-31 0001077428 us-gaap:TreasuryStockCommonMember 2025-03-31 0001077428 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001077428 us-gaap:USTreasurySecuritiesMember 2025-03-31 0001077428 us-gaap:ResidentialMortgageBackedSecuritiesMember 2025-03-31 0001077428 us-gaap:CommercialMortgageBackedSecuritiesMember 2025-03-31 0001077428 us-gaap:CreditRiskContractMember 2025-03-31 0001077428 us-gaap:USTreasurySecuritiesMember 2024-12-31 0001077428 us-gaap:ResidentialMortgageBackedSecuritiesMember 2024-12-31 0001077428 us-gaap:CommercialMortgageBackedSecuritiesMember 2024-12-31 0001077428 us-gaap:CreditRiskContractMember 2024-12-31 0001077428 us-gaap:AvailableforsaleSecuritiesMember 2025-03-31 0001077428 us-gaap:AvailableforsaleSecuritiesMember 2024-12-31 0001077428 us-gaap:HeldtomaturitySecuritiesMember 2025-03-31 0001077428 us-gaap:HeldtomaturitySecuritiesMember 2024-12-31 0001077428 us-gaap:MortgageBackedSecuritiesMember 2025-03-31 0001077428 us-gaap:BankTimeDepositsMember 2025-03-31 0001077428 us-gaap:BankTimeDepositsMember 2024-12-31 0001077428 us-gaap:CommercialPortfolioSegmentMember 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember 2024-12-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember 2025-03-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember 2024-12-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember 2024-12-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember 2025-03-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember 2024-12-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:PassMember 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:SpecialMentionMember 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember tcbi:NonAccrualMember 2025-03-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember us-gaap:PassMember 2025-03-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember us-gaap:SpecialMentionMember 2025-03-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember us-gaap:SubstandardMember 2025-03-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember tcbi:NonAccrualMember 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:PassMember 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:SpecialMentionMember 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:SubstandardMember 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember tcbi:NonAccrualMember 2025-03-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember us-gaap:PassMember 2025-03-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember us-gaap:SpecialMentionMember 2025-03-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember us-gaap:SubstandardMember 2025-03-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember tcbi:NonAccrualMember 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:PassMember 2024-12-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:SpecialMentionMember 2024-12-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2024-12-31 0001077428 us-gaap:CommercialPortfolioSegmentMember tcbi:NonAccrualMember 2024-12-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember us-gaap:PassMember 2024-12-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember us-gaap:SpecialMentionMember 2024-12-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember us-gaap:SubstandardMember 2024-12-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember tcbi:NonAccrualMember 2024-12-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:PassMember 2024-12-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:SpecialMentionMember 2024-12-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:SubstandardMember 2024-12-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember tcbi:NonAccrualMember 2024-12-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember us-gaap:PassMember 2024-12-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember us-gaap:SpecialMentionMember 2024-12-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember us-gaap:SubstandardMember 2024-12-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember tcbi:NonAccrualMember 2024-12-31 0001077428 2024-01-01 2024-12-31 0001077428 us-gaap:CommercialPortfolioSegmentMember 2025-01-01 2025-03-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember 2025-01-01 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember 2025-01-01 2025-03-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember 2025-01-01 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember 2023-12-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember 2023-12-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember 2023-12-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember 2023-12-31 0001077428 us-gaap:CommercialPortfolioSegmentMember 2024-01-01 2024-03-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember 2024-01-01 2024-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember 2024-01-01 2024-03-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember 2024-01-01 2024-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember 2024-03-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember 2024-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember 2024-03-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember 2024-03-31 0001077428 us-gaap:CriticizedMember 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:AssetPledgedAsCollateralMember 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:AssetPledgedAsCollateralMember 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancialAssetPastDueMember 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancialAssetNotPastDueMember 2025-03-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2025-03-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2025-03-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2025-03-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember us-gaap:FinancialAssetPastDueMember 2025-03-31 0001077428 tcbi:MortgageFinancePortfolioSegmentMember us-gaap:FinancialAssetNotPastDueMember 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancialAssetPastDueMember 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancialAssetNotPastDueMember 2025-03-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember us-gaap:FinancingReceivables30To59DaysPastDueMember 2025-03-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2025-03-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2025-03-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember us-gaap:FinancialAssetPastDueMember 2025-03-31 0001077428 us-gaap:ConsumerPortfolioSegmentMember us-gaap:FinancialAssetNotPastDueMember 2025-03-31 0001077428 us-gaap:FinancingReceivables30To59DaysPastDueMember 2025-03-31 0001077428 us-gaap:FinancingReceivables60To89DaysPastDueMember 2025-03-31 0001077428 us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2025-03-31 0001077428 us-gaap:FinancialAssetPastDueMember 2025-03-31 0001077428 us-gaap:FinancialAssetNotPastDueMember 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:PaymentDeferralMember 2025-01-01 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember tcbi:TermExtensionMember 2025-01-01 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember tcbi:PaymentDeferralAndTermExtensionMember 2025-01-01 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:ExtendedMaturityAndInterestRateReductionMember 2025-01-01 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember srt:MinimumMember 2025-01-01 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember srt:MaximumMember 2025-01-01 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:PaymentDeferralMember 2025-01-01 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember tcbi:TermExtensionMember 2025-01-01 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember tcbi:PaymentDeferralAndTermExtensionMember 2025-01-01 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:ExtendedMaturityAndInterestRateReductionMember 2025-01-01 2025-03-31 0001077428 us-gaap:PaymentDeferralMember 2025-01-01 2025-03-31 0001077428 tcbi:TermExtensionMember 2025-01-01 2025-03-31 0001077428 tcbi:PaymentDeferralAndTermExtensionMember 2025-01-01 2025-03-31 0001077428 us-gaap:ExtendedMaturityAndInterestRateReductionMember 2025-01-01 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:PaymentDeferralMember 2024-01-01 2024-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember tcbi:TermExtensionMember 2024-01-01 2024-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember tcbi:PaymentDeferralAndTermExtensionMember 2024-01-01 2024-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:ExtendedMaturityAndInterestRateReductionMember 2024-01-01 2024-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember srt:MinimumMember 2024-01-01 2024-03-31 0001077428 us-gaap:PaymentDeferralMember 2024-01-01 2024-03-31 0001077428 tcbi:TermExtensionMember 2024-01-01 2024-03-31 0001077428 tcbi:PaymentDeferralAndTermExtensionMember 2024-01-01 2024-03-31 0001077428 us-gaap:ExtendedMaturityAndInterestRateReductionMember 2024-01-01 2024-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember tcbi:FinancialAsset30To89DaysPastDueMember 2025-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember tcbi:FinancialAsset30To89DaysPastDueMember 2025-03-31 0001077428 tcbi:FinancialAsset30To89DaysPastDueMember 2025-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember tcbi:FinancialAsset30To89DaysPastDueMember 2024-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2024-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancialAssetPastDueMember 2024-03-31 0001077428 us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancialAssetNotPastDueMember 2024-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember tcbi:FinancialAsset30To89DaysPastDueMember 2024-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2024-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancialAssetPastDueMember 2024-03-31 0001077428 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:FinancialAssetNotPastDueMember 2024-03-31 0001077428 tcbi:FinancialAsset30To89DaysPastDueMember 2024-03-31 0001077428 us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2024-03-31 0001077428 us-gaap:FinancialAssetPastDueMember 2024-03-31 0001077428 us-gaap:FinancialAssetNotPastDueMember 2024-03-31 0001077428 us-gaap:FederalHomeLoanBankAdvancesMember 2025-03-31 0001077428 us-gaap:FederalHomeLoanBankAdvancesMember 2024-12-31 0001077428 tcbi:A5.25SubordinatedNotesDue2026Member 2014-01-31 0001077428 tcbi:A5.25SubordinatedNotesDue2026Member 2025-03-31 0001077428 tcbi:A5.25SubordinatedNotesDue2026Member 2024-12-31 0001077428 tcbi:A400SubordinatedNotesDue2031Member 2021-05-06 0001077428 tcbi:A400SubordinatedNotesDue2031Member 2025-03-31 0001077428 tcbi:A400SubordinatedNotesDue2031Member 2024-12-31 0001077428 tcbi:FloatingRateSubordinatedDebenturesDue2032To2036Member 2025-03-31 0001077428 tcbi:FloatingRateSubordinatedDebenturesDue2032To2036Member 2024-12-31 0001077428 us-gaap:CommitmentsToExtendCreditMember 2025-03-31 0001077428 us-gaap:CommitmentsToExtendCreditMember 2024-12-31 0001077428 us-gaap:StandbyLettersOfCreditMember 2025-03-31 0001077428 us-gaap:StandbyLettersOfCreditMember 2024-12-31 0001077428 tcbi:AdvancedApproachPhasedInMember 2025-03-31 0001077428 tcbi:January2024ShareRepurchaseProgramMember 2024-01-17 0001077428 tcbi:January2023ShareRepurchaseProgramMember 2025-01-01 2025-03-31 0001077428 2009-12-31 0001077428 tcbi:AdvancedApproachPhaseInScheduleMember 2025-03-31 0001077428 tcbi:AdvancedApproachPhaseInScheduleMember srt:SubsidiariesMember 2025-03-31 0001077428 srt:SubsidiariesMember 2025-03-31 0001077428 srt:SubsidiariesMember 2024-12-31 0001077428 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-03-31 0001077428 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0001077428 us-gaap:PerformanceSharesMember 2025-01-01 2025-03-31 0001077428 us-gaap:PerformanceSharesMember 2024-01-01 2024-03-31 0001077428 tcbi:StockSettledAwardsMember 2025-03-31 0001077428 tcbi:StockSettledAwardsMember 2025-01-01 2025-03-31 0001077428 tcbi:CashSettledUnitsMember 2025-03-31 0001077428 tcbi:CashSettledUnitsMember 2025-01-01 2025-03-31 0001077428 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2025-03-31 0001077428 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2025-03-31 0001077428 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2025-03-31 0001077428 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2025-03-31 0001077428 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2025-03-31 0001077428 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2025-03-31 0001077428 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2025-03-31 0001077428 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2025-03-31 0001077428 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2025-03-31 0001077428 us-gaap:CreditRiskContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2025-03-31 0001077428 us-gaap:CreditRiskContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2025-03-31 0001077428 us-gaap:CreditRiskContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2025-03-31 0001077428 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2025-03-31 0001077428 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2025-03-31 0001077428 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2025-03-31 0001077428 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2024-12-31 0001077428 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2024-12-31 0001077428 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0001077428 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2024-12-31 0001077428 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2024-12-31 0001077428 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0001077428 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2024-12-31 0001077428 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2024-12-31 0001077428 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0001077428 us-gaap:CreditRiskContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2024-12-31 0001077428 us-gaap:CreditRiskContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2024-12-31 0001077428 us-gaap:CreditRiskContractMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0001077428 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2024-12-31 0001077428 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2024-12-31 0001077428 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0001077428 us-gaap:CreditRiskContractMember 2024-12-31 0001077428 us-gaap:CreditRiskContractMember 2025-01-01 2025-03-31 0001077428 us-gaap:CreditRiskContractMember 2025-03-31 0001077428 us-gaap:CreditRiskContractMember 2023-12-31 0001077428 us-gaap:CreditRiskContractMember 2024-01-01 2024-03-31 0001077428 us-gaap:CreditRiskContractMember 2024-03-31 0001077428 us-gaap:AssetBackedSecuritiesMember 2025-01-01 2025-03-31 0001077428 us-gaap:AssetBackedSecuritiesMember 2024-01-01 2024-03-31 0001077428 us-gaap:CreditRiskContractMember srt:MinimumMember us-gaap:MeasurementInputDiscountRateMember 2025-03-31 0001077428 us-gaap:CreditRiskContractMember srt:MaximumMember us-gaap:MeasurementInputDiscountRateMember 2025-03-31 0001077428 srt:MinimumMember us-gaap:CreditRiskContractMember 2025-03-31 0001077428 srt:MaximumMember us-gaap:CreditRiskContractMember 2025-03-31 0001077428 us-gaap:CreditRiskContractMember srt:WeightedAverageMember us-gaap:MeasurementInputDiscountRateMember 2025-03-31 0001077428 us-gaap:CreditRiskContractMember srt:WeightedAverageMember us-gaap:MeasurementInputDiscountRateMember 2024-12-31 0001077428 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel3Member 2025-03-31 0001077428 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel3Member 2025-01-01 2025-03-31 0001077428 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0001077428 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel3Member 2024-01-01 2024-06-30 0001077428 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2025-03-31 0001077428 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-03-31 0001077428 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel1Member 2025-03-31 0001077428 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel2Member 2025-03-31 0001077428 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member 2025-03-31 0001077428 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2024-12-31 0001077428 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-12-31 0001077428 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel1Member 2024-12-31 0001077428 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel2Member 2024-12-31 0001077428 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0001077428 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2025-03-31 0001077428 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2024-12-31 0001077428 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember tcbi:CustomerInitiatedAndOtherDerivativesMember 2025-03-31 0001077428 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember tcbi:CustomerInitiatedAndOtherDerivativesMember 2024-12-31 0001077428 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember tcbi:CustomerInitiatedAndOtherDerivativesMember 2025-03-31 0001077428 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember tcbi:CustomerInitiatedAndOtherDerivativesMember 2024-12-31 0001077428 tcbi:InterestRateCapsAndFloorsWrittenMember us-gaap:NondesignatedMember tcbi:CustomerInitiatedAndOtherDerivativesMember 2025-03-31 0001077428 tcbi:InterestRateCapsAndFloorsWrittenMember us-gaap:NondesignatedMember tcbi:CustomerInitiatedAndOtherDerivativesMember 2024-12-31 0001077428 tcbi:InterestRateCapsAndFloorsPurchasedMember us-gaap:NondesignatedMember tcbi:CustomerInitiatedAndOtherDerivativesMember 2025-03-31 0001077428 tcbi:InterestRateCapsAndFloorsPurchasedMember us-gaap:NondesignatedMember tcbi:CustomerInitiatedAndOtherDerivativesMember 2024-12-31 0001077428 us-gaap:ForwardContractsMember us-gaap:NondesignatedMember tcbi:CustomerInitiatedAndOtherDerivativesMember 2025-03-31 0001077428 us-gaap:ForwardContractsMember us-gaap:NondesignatedMember tcbi:CustomerInitiatedAndOtherDerivativesMember 2024-12-31 0001077428 us-gaap:NondesignatedMember us-gaap:LoansReceivableMember 2025-03-31 0001077428 us-gaap:NondesignatedMember us-gaap:LoansReceivableMember 2024-12-31 0001077428 tcbi:RiskParticipationAgreementParticipantBankMember 2025-03-31 0001077428 tcbi:RiskParticipationAgreementParticipantBankMember 2024-12-31 0001077428 tcbi:RiskParticipationAgreementsLeadBankMember 2025-03-31 0001077428 tcbi:RiskParticipationAgreementsLeadBankMember 2024-12-31 0001077428 us-gaap:InterestRateContractMember 2025-01-01 2025-03-31 0001077428 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-12-31 0001077428 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-12-31 0001077428 tcbi:AOCIAccumulatedGainLossDebtSecuritiesHeldToMaturityParentMember 2024-12-31 0001077428 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-01-01 2025-03-31 0001077428 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2025-01-01 2025-03-31 0001077428 tcbi:AOCIAccumulatedGainLossDebtSecuritiesHeldToMaturityParentMember 2025-01-01 2025-03-31 0001077428 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-03-31 0001077428 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2025-03-31 0001077428 tcbi:AOCIAccumulatedGainLossDebtSecuritiesHeldToMaturityParentMember 2025-03-31 0001077428 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31 0001077428 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-12-31 0001077428 tcbi:AOCIAccumulatedGainLossDebtSecuritiesHeldToMaturityParentMember 2023-12-31 0001077428 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-03-31 0001077428 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-01-01 2024-03-31 0001077428 tcbi:AOCIAccumulatedGainLossDebtSecuritiesHeldToMaturityParentMember 2024-01-01 2024-03-31 0001077428 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-03-31 0001077428 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-03-31 0001077428 tcbi:AOCIAccumulatedGainLossDebtSecuritiesHeldToMaturityParentMember 2024-03-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
For the quarterly period ended March 31, 2025
Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
For the transition period from to
Commission file number 001-34657
TEXAS CAPITAL BANCSHARES, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware 75-2679109
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number)
2000 McKinney Avenue
Suite 700
Dallas TX USA 75201
(Address of principal executive offices) (Zip Code)
(214) 932-6600
(Registrant’s telephone number, including area code)

Securities registered under Section 12(b) of the Exchange Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share TCBI
The Nasdaq Stock Market
5.75% Non-Cumulative Perpetual Preferred Stock Series B, par value $0.01 per share TCBIO
The Nasdaq Stock Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large Accelerated Filer x Accelerated Filer
Non-Accelerated Filer Smaller Reporting Company
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act. Yes No ý
On April 15, 2025, the number of shares set forth below was outstanding with respect to each of the issuer’s classes of common stock:
Common Stock, par value $0.01 per share 45,903,380


Texas Capital Bancshares, Inc.
Form 10-Q
Quarter Ended March 31, 2025

Index
Item 1.
Item 2.
Item 3.
Item 4.
Item 1.
Item 1A.
Item 2.
Item 6.



PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
TEXAS CAPITAL BANCSHARES, INC.
CONSOLIDATED BALANCE SHEETS - UNAUDITED
(in thousands except share data) March 31, 2025 December 31, 2024
Assets
Cash and due from banks $ 201,504 $ 176,501
Interest bearing cash and cash equivalents 3,600,969 3,012,307
Available-for-sale debt securities 3,678,378 3,524,686
Held-to-maturity debt securities 779,354 796,168
Equity securities 71,679 75,261
Trading securities 1,808
Investment securities 4,531,219 4,396,115
Loans held for sale
Loans held for investment, mortgage finance 4,725,541 5,215,574
Loans held for investment 17,654,243 17,234,492
Less: Allowance for credit losses on loans 278,379 271,709
Loans held for investment, net 22,101,405 22,178,357
Premises and equipment, net 84,575 85,443
Accrued interest receivable and other assets 854,581 881,664
Goodwill and intangibles, net 1,496 1,496
Total assets $ 31,375,749 $ 30,731,883
Liabilities and Stockholders’ Equity
Liabilities:
Non-interest bearing deposits $ 7,874,780 $ 7,485,428
Interest bearing deposits 18,178,254 17,753,171
Total deposits 26,053,034 25,238,599
Accrued interest payable 25,270 23,680
Other liabilities 457,150 556,322
Short-term borrowings 750,000 885,000
Long-term debt 660,521 660,346
Total liabilities 27,945,975 27,363,947
Stockholders’ equity:
Preferred stock, $ 0.01 par value, $ 1,000 liquidation value:
Authorized shares - 10,000,000
Issued shares - 300,000 at March 31, 2025 and December 31, 2024
300,000 300,000
Common stock, $ 0.01 par value:
Authorized shares - 100,000,000
Issued shares - 51,707,542 and 51,520,315 at March 31, 2025 and December 31, 2024, respectively
517 515
Additional paid-in capital 1,060,028 1,056,719
Retained earnings 2,538,385 2,495,651
Treasury stock - 5,682,609 and 5,286,503 shares at cost at March 31, 2025 and December 31, 2024, respectively
( 332,994 ) ( 301,842 )
Accumulated other comprehensive loss, net of taxes ( 136,162 ) ( 183,107 )
Total stockholders’ equity 3,429,774 3,367,936
Total liabilities and stockholders’ equity $ 31,375,749 $ 30,731,883
See accompanying notes to consolidated financial statements.
3

TEXAS CAPITAL BANCSHARES, INC.
CONSOLIDATED STATEMENTS OF INCOME AND OTHER
COMPREHENSIVE INCOME - UNAUDITED
Three Months Ended March 31,
(in thousands except per share data) 2025 2024
Interest income
Interest and fees on loans $ 334,150 $ 330,879
Investment securities 46,565 32,144
Interest bearing cash and cash equivalents 46,574 54,355
Total interest income 427,289 417,378
Interest expense
Deposits 174,936 175,600
Short-term borrowings 8,246 12,783
Long-term debt 8,073 13,986
Total interest expense 191,255 202,369
Net interest income 236,034 215,009
Provision for credit losses 17,000 19,000
Net interest income after provision for credit losses 219,034 196,009
Non-interest income
Service charges on deposit accounts 7,840 6,339
Wealth management and trust fee income 3,964 3,567
Brokered loan fees 1,949 1,911
Investment banking and advisory fees 16,478 18,424
Trading income 5,939 4,712
Other 8,274 6,366
Total non-interest income 44,444 41,319
Non-interest expense
Salaries and benefits 131,641 128,727
Occupancy expense 10,844 9,737
Marketing 5,009 6,036
Legal and professional 14,989 16,195
Communications and technology 23,642 21,114
Federal Deposit Insurance Corporation insurance assessment 5,341 8,421
Other 11,554 12,163
Total non-interest expense 203,020 202,393
Income before income taxes 60,458 34,935
Income tax expense 13,411 8,793
Net income 47,047 26,142
Preferred stock dividends 4,313 4,313
Net income available to common stockholders $ 42,734 $ 21,829
Other comprehensive income/(loss)
Change in unrealized gain/(loss) $ 50,279 $ ( 42,343 )
Amounts reclassified into net income
10,359 19,708
Other comprehensive income/(loss) 60,638 ( 22,635 )
Income tax expense/(benefit) 13,693 ( 4,753 )
Other comprehensive income/(loss), net of tax 46,945 ( 17,882 )
Comprehensive income $ 93,992 $ 8,260
Basic earnings per common share
$ 0.93 $ 0.46
Diluted earnings per common share
$ 0.92 $ 0.46
See accompanying notes to consolidated financial statements.
4

TEXAS CAPITAL BANCSHARES, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - UNAUDITED

Preferred Stock Common Stock Additional Treasury Stock Accumulated Other
Paid-in Retained Comprehensive
(in thousands except share data) Shares Amount Shares Amount Capital Earnings Shares Amount Income/(Loss) Total
Balance at December 31, 2023 (audited)
300,000 $ 300,000 51,142,979 $ 511 $ 1,045,576 $ 2,435,393 ( 3,905,067 ) $ ( 220,334 ) $ ( 362,004 ) $ 3,199,142
Comprehensive income/(loss):
Net income 26,142 26,142
Change in other comprehensive income/(loss), net of taxes
( 17,882 ) ( 17,882 )
Total comprehensive income
8,260
Stock-based compensation expense recognized in earnings
8,026 8,026
Preferred stock dividend ( 4,313 ) ( 4,313 )
Issuance of stock related to stock-based awards
277,701 3 ( 8,933 ) ( 8,930 )
Repurchase of common stock ( 529,338 ) ( 31,523 ) ( 31,523 )
Balance at March 31, 2024 300,000 $ 300,000 51,420,680 $ 514 $ 1,044,669 $ 2,457,222 ( 4,434,405 ) $ ( 251,857 ) $ ( 379,886 ) $ 3,170,662
Balance at December 31, 2024 (audited)
300,000 $ 300,000 51,520,315 $ 515 $ 1,056,719 $ 2,495,651 ( 5,286,503 ) $ ( 301,842 ) $ ( 183,107 ) $ 3,367,936
Comprehensive income/(loss):
Net income
47,047 47,047
Change in other comprehensive income/(loss), net of taxes 46,945 46,945
Total comprehensive income 93,992
Stock-based compensation expense recognized in earnings
10,359 10,359
Preferred stock dividend ( 4,313 ) ( 4,313 )
Issuance of stock related to stock-based awards
187,227 2 ( 7,050 ) ( 7,048 )
Repurchase of common stock ( 396,106 ) ( 31,152 ) ( 31,152 )
Balance at March 31, 2025 300,000 $ 300,000 51,707,542 $ 517 $ 1,060,028 $ 2,538,385 ( 5,682,609 ) $ ( 332,994 ) $ ( 136,162 ) $ 3,429,774
See accompanying notes to consolidated financial statements.
5

TEXAS CAPITAL BANCSHARES, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
Three Months Ended March 31,
(in thousands) 2025 2024
Operating activities
Net income $ 47,047 $ 26,142
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses 17,000 19,000
Depreciation and amortization 9,217 10,906
Net (gain)/loss recognized on investment securities 2,052 ( 4,034 )
Sales/(purchases) of trading securities, net ( 1,824 )
Stock-based compensation expense 12,750 8,534
Proceeds from sales and repayments of loans held for sale 15,605
Changes in operating assets and liabilities:
Accrued interest receivable and other assets 4,604 48,253
Accrued interest payable and other liabilities ( 90,478 ) ( 28,586 )
Net cash provided by operating activities 368 95,820
Investing activities
Purchases of available-for-sale debt securities ( 198,597 ) ( 596,610 )
Proceeds from maturities, redemptions and pay-downs of available-for-sale debt securities 97,698 317,717
Proceeds from maturities, redemptions and pay-downs of held-to-maturity debt securities 17,659 17,064
Sales/(purchases) of equity securities, net 1,546 ( 17,628 )
Originations of loans held for investment, mortgage finance ( 18,466,846 ) ( 16,389,564 )
Proceeds from pay-offs of loans held for investment, mortgage finance 18,956,879 16,214,579
Net increase in loans held for investment, excluding mortgage finance loans ( 429,548 ) ( 335,475 )
Purchase of premises and equipment, net ( 2,416 ) ( 20,043 )
Net cash used in investing activities ( 23,625 ) ( 809,960 )
Financing activities
Net increase/(decrease) in deposits 814,435 1,582,198
Issuance of stock related to stock-based awards ( 7,048 ) ( 8,930 )
Preferred stock dividends paid ( 4,313 ) ( 4,313 )
Repurchase of common stock ( 31,152 ) ( 31,523 )
Net increase/(decrease) in short-term borrowings ( 135,000 ) ( 750,000 )
Net cash provided by financing activities 636,922 787,432
Net increase in cash and cash equivalents 613,665 73,292
Cash and cash equivalents at beginning of period 3,188,808 3,242,850
Cash and cash equivalents at end of period $ 3,802,473 $ 3,316,142
Supplemental disclosures of cash flow information
Cash paid during the period for interest $ 189,665 $ 267,955
Cash received during the period for income taxes
( 1,290 ) ( 909 )
Transfers of loans from held for investment to held for sale 9,250
See accompanying notes to consolidated financial statements.
6

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED
(1) Operations and Summary of Significant Accounting Policies
Organization and Nature of Business
Texas Capital Bancshares, Inc. (“TCBI” or the “Company”) is a registered bank holding company and a full-service financial services firm that delivers customized solutions to businesses, entrepreneurs and individual customers. TCBI is headquartered in Dallas, with primary banking offices in Austin, Dallas, Fort Worth, Houston and San Antonio, and has built a network of clients across the country.
The Company’s business activities are conducted primarily through its wholly-owned bank subsidiary Texas Capital Bank (the “Bank”) and its wholly-owned non-bank subsidiary, TCBI Securities Inc. (“TCBI Securities”). The Bank is a Texas state-chartered bank. TCBI Securities is a registered broker-dealer with the U.S. Securities and Exchange Commission (“SEC”) and a member of the Financial Industry Regulatory Authority and Municipal Securities Rulemaking Board.
The Company was incorporated as a Delaware corporation in 1996 and commenced banking operations in 1998.
Basis of Presentation
The Company’s accounting and reporting policies conform to accounting principles generally accepted in the United States (“GAAP”) and to generally accepted practices within the banking industry. Certain prior period balances have been reclassified to conform to the current period presentation.
The consolidated interim financial statements are unaudited, and certain information and disclosures in the notes to consolidated unaudited financial statements that are presented in accordance with GAAP have been condensed or omitted. In the opinion of management, the interim financial statements include all normal and recurring adjustments and the disclosures made present a fair presentation of the Company’s financial position and results of operations. The consolidated financial statements have been prepared in accordance with GAAP for interim financial information and the instructions to Form 10-Q adopted by the SEC. Accordingly, the financial statements and the notes to the consolidated unaudited financial statements required by GAAP for complete annual financial statements do not include all of the information and should be read in conjunction with the consolidated financial statements, and notes thereto, for the year ended December 31, 2024, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 (the “2024 Form 10-K”). Operating results for the interim periods disclosed herein are not necessarily indicative of the results that may be expected for a full year or any future period.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates. The allowance for credit losses, the fair value of financial instruments and the status of contingencies are particularly susceptible to significant change.
(2) Earnings Per Share
The following table presents the computation of basic and diluted earnings per share:
Three Months Ended March 31,
(in thousands except share and per share data) 2025 2024
Numerator:
Net income
$ 47,047 $ 26,142
Preferred stock dividends 4,313 4,313
Net income available to common stockholders
$ 42,734 $ 21,829
Denominator:
Basic earnings per common share—weighted average common shares 46,123,416 47,278,681
Effect of dilutive outstanding stock-settled awards 493,288 432,511
Dilutive earnings per common share—weighted average diluted common shares 46,616,704 47,711,192
Basic earnings per common share
$ 0.93 $ 0.46
Diluted earnings per common share
$ 0.92 $ 0.46
Anti-dilutive outstanding stock-settled awards 22,707 127,145
7

(3) Investment Securities
The following is a summary of the Company’s investment securities:
(in thousands) Amortized
Cost(1)
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated
Fair
Value
March 31, 2025
Available-for-sale debt securities:
U.S. Treasury securities $ 282,053 $ $ ( 1,954 ) $ 280,099
Residential mortgage-backed securities 3,264,089 11,603 ( 129,561 ) 3,146,131
Commercial mortgage-backed securities
240,342 1,738 ( 1,526 ) 240,554
CRT securities 12,165 ( 571 ) 11,594
Total available-for-sale debt securities 3,798,649 13,341 ( 133,612 ) 3,678,378
Held-to-maturity debt securities:
Residential mortgage-backed securities 779,354 ( 93,692 ) 685,662
Total held-to-maturity debt securities 779,354 ( 93,692 ) 685,662
Equity securities 71,679
Trading securities 1,808
Total investment securities(2) $ 4,531,219
December 31, 2024
Available-for-sale debt securities:
U.S. Treasury securities $ 280,137 $ $ ( 2,852 ) $ 277,285
Residential mortgage-backed securities 3,195,145 7,200 ( 168,302 ) 3,034,043
Commercial mortgage-backed securities
206,830 ( 5,398 ) 201,432
CRT securities 12,466 ( 540 ) 11,926
Total available-for-sale debt securities 3,694,578 7,200 ( 177,092 ) 3,524,686
Held-to-maturity securities:
Residential mortgage-backed securities 796,168 ( 117,994 ) 678,174
Total held-to-maturity securities 796,168 ( 117,994 ) 678,174
Equity securities 75,261
Total investment securities(2) $ 4,396,115
(1)    Excludes accrued interest receivable of $ 14.2 million and $ 13.8 million at March 31, 2025 and December 31, 2024, respectively, related to available-for-sale debt securities and $ 1.3 million and $ 1.3 million at March 31, 2025 and December 31, 2024, respectively, related to held-to-maturity debt securities that is recorded in accrued interest receivable and other assets on the consolidated balance sheets.
(2)    Includes available-for-sale debt securities, equity securities and trading securities at estimated fair value and held-to-maturity debt securities at amortized cost.
Debt Securities
The Company did not sell any available-for-sale debt securities during the first three months of 2025 or 2024.
The amortized cost and estimated fair value as of March 31, 2025, excluding accrued interest receivable, of available-for-sale and held-to-maturity debt securities are presented below by contractual maturity. Actual maturities may differ from contractual maturities of mortgage-backed securities because borrowers may have the right to call or prepay obligations with or without prepayment penalties.
Available-for-sale Held-to-maturity
(in thousands) Amortized Cost Fair Value Amortized Cost Fair Value
Due within one year $ 282,053 $ 280,099 $ $
Due after one year through five years
Due after five years through ten years 230,060 229,911
Due after ten years 3,286,536 3,168,368 779,354 685,662
Total $ 3,798,649 $ 3,678,378 $ 779,354 $ 685,662
8

The table below presents the weighted average yields for the Company’s available-for-sale debt securities for the three months ended March 31, 2025. Weighted average yields are calculated based on amortized cost on a tax-exempt basis assuming a 21% federal tax rate, where applicable.
U.S. Treasury securities Residential mortgage-backed securities
Commercial mortgage-backed securities
CRT securities
Due within one year 3.13 % % % %
Due after one year through five years
Due after five years through ten years 3.87 4.83 4.44
Due after ten years 4.62 4.35
Total 3.13 % 4.62 % 4.79 % 4.44 %
The following table discloses the Company’s available-for-sale debt securities that have been in a continuous unrealized loss position for less than 12 months and those that have been in a continuous unrealized loss position for 12 or more months:
Less Than 12 Months 12 Months or Longer Total
(in thousands) Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss
March 31, 2025
U.S. Treasury securities $ $ $ 280,099 $ ( 1,954 ) $ 280,099 $ ( 1,954 )
Residential mortgage-backed securities 1,338,655 ( 4,822 ) 1,289,319 ( 124,739 ) 2,627,974 ( 129,561 )
Commercial mortgage-backed securities
155,810 ( 1,526 ) 155,810 ( 1,526 )
CRT securities 11,594 ( 571 ) 11,594 ( 571 )
Total $ 1,494,465 $ ( 6,348 ) $ 1,581,012 $ ( 127,264 ) $ 3,075,477 $ ( 133,612 )
December 31, 2024
U.S. Treasury securities $ $ $ 277,285 $ ( 2,852 ) $ 277,285 $ ( 2,852 )
Residential mortgage-backed securities 1,338,801 ( 18,141 ) 1,323,180 ( 150,161 ) 2,661,981 ( 168,302 )
Commercial mortgage-backed securities
201,432 ( 5,398 ) 201,432 ( 5,398 )
CRT securities 11,926 ( 540 ) 11,926 ( 540 )
Total $ 1,540,233 $ ( 23,539 ) $ 1,612,391 $ ( 153,553 ) $ 3,152,624 $ ( 177,092 )
At March 31, 2025, the Company had 55 available-for-sale debt securities in an unrealized loss position, comprised of 6 U.S. Treasury securities, 42 residential mortgage-backed securities, 5 commercial mortgage-backed securities and two Credit Risk Transfer (“CRT”) securities. The unrealized losses on the available-for-sale debt securities were the result of changes in market interest rates compared to the date the securities were acquired rather than the credit quality of the issuers or underlying loans. The Company does not currently intend to sell and based on current conditions it does not believe it is likely that the Company will be required to sell these available-for-sale debt securities before recovery of the amortized cost of such securities in an unrealized loss position and has therefore recorded the unrealized losses related to this portfolio in accumulated other comprehensive income/loss, net (“AOCI”). Held-to-maturity securities consist of government guaranteed securities for which no loss is expected. At March 31, 2025 and December 31, 2024, no allowance for credit losses was established for available-for-sale or held-to-maturity debt securities.
At March 31, 2025 and December 31, 2024, debt securities with carrying values of approximately $ 913,000 and $ 940,000 , respectively, were pledged to secure certain customer deposits.
Equi ty Securities
Equity securities consist of investments that qualify for consideration under the regulations implementing the Community Reinvestment Act and investments in exchange traded funds. The following is a summary of unrealized and realized gains/(losses) recognized on equity securities included in other non-interest income on the consolidated statements of income and other comprehensive income:
Three Months Ended March 31,
(in thousands) 2025 2024
Net gains/(losses) recognized during the period $ ( 1,708 ) $ 4,034
Less: Realized net gains/(losses) recognized on securities sold 328 312
Unrealized net gains/(losses) recognized on securities still held $ ( 2,036 ) $ 3,722
9

(4) Loans and Allowance for Credit Losses on Loans
Loans are summarized by portfolio segment as follows:
(in thousands) March 31, 2025 December 31, 2024
Loans held for investment(1):
Commercial $ 11,404,294 $ 11,145,591
Mortgage finance 4,725,541 5,215,574
Commercial real estate 5,823,987 5,616,282
Consumer 521,253 565,376
Gross loans held for investment 22,475,075 22,542,823
Unearned income (net of direct origination costs) ( 95,291 ) ( 92,757 )
Total loans held for investment 22,379,784 22,450,066
Allowance for credit losses on loans ( 278,379 ) ( 271,709 )
Total loans held for investment, net $ 22,101,405 $ 22,178,357
(1)    Excludes accrued interest receivable of $ 102.1 million and $ 107.3 million at March 31, 2025 and December 31, 2024, respectively, that is recorded in accrued interest receivable and other assets on the consolidated balance sheets.

10

The following tables summarize gross loans held for investment by year of origination and internally assigned credit grades:
(in thousands) 2025 2024 2023 2022 2021 2020
and prior
Revolving lines of credit Revolving lines of credit converted to term loans Total
March 31, 2025
Commercial
(1-7) Pass $ 246,092 $ 1,510,510 $ 1,053,890 $ 1,153,375 $ 278,453 $ 206,130 $ 6,376,270 $ 11,809 $ 10,836,529
(8) Special mention 95 28,270 44,350 147,876 23,983 4,802 76,719 18,905 345,000
(9) Substandard - accruing 24 580 40,449 37,731 7,274 3,228 73,691 162,977
(9+) Non-accrual 8,623 4,030 21,830 25,305 59,788
Total commercial $ 246,211 $ 1,539,360 $ 1,147,312 $ 1,343,012 $ 309,710 $ 235,990 $ 6,551,985 $ 30,714 $ 11,404,294
Mortgage finance
(1-7) Pass $ $ $ $ $ $ $ 4,725,541 $ $ 4,725,541
(8) Special mention
(9) Substandard - accruing
(9+) Non-accrual
Total mortgage finance $ $ $ $ $ $ $ 4,725,541 $ $ 4,725,541
Commercial real estate
(1-7) Pass $ 129,486 $ 624,923 $ 956,181 $ 1,902,158 $ 845,006 $ 887,128 $ 274,724 $ 12,983 $ 5,632,589
(8) Special mention 25,532 5,781 70,158 19,120 14,005 845 135,441
(9) Substandard - accruing 3,034 19,146 22,180
(9+) Non-accrual 20,277 13,500 33,777
Total commercial real estate $ 129,486 $ 650,455 $ 964,996 $ 1,992,593 $ 864,126 $ 933,779 $ 274,724 $ 13,828 $ 5,823,987
Consumer
(1-7) Pass $ 6,817 $ 39,708 $ 28,914 $ 52,991 $ 75,499 $ 125,286 $ 188,314 $ $ 517,529
(8) Special mention 2,724 1,000 3,724
(9) Substandard - accruing
(9+) Non-accrual
Total consumer $ 6,817 $ 42,432 $ 28,914 $ 52,991 $ 75,499 $ 125,286 $ 189,314 $ $ 521,253
Total $ 382,514 $ 2,232,247 $ 2,141,222 $ 3,388,596 $ 1,249,335 $ 1,295,055 $ 11,741,564 $ 44,542 $ 22,475,075
Gross charge-offs $ $ 86 $ 116 $ 4,018 $ $ 415 $ 6,062 $ $ 10,697
(in thousands) 2024 2023 2022 2021 2020 2019
and prior
Revolving lines of credit Revolving lines of credit converted to term loans Total
December 31, 2024
Commercial
(1-7) Pass $ 1,612,695 $ 1,156,414 $ 1,256,539 $ 307,590 $ 76,821 $ 169,974 $ 6,027,177 $ 12,040 $ 10,619,250
(8) Special mention 22,953 28,354 134,092 21,626 30 6,369 91,423 304,847
(9) Substandard - accruing 623 44,901 51,536 7,855 301 3,309 37,405 145,930
(9+) Non-accrual 9,220 8,057 360 23,708 34,219 75,564
Total commercial $ 1,636,271 $ 1,238,889 $ 1,450,224 $ 337,071 $ 77,512 $ 203,360 $ 6,190,224 $ 12,040 $ 11,145,591
Mortgage finance
(1-7) Pass $ $ $ $ $ $ $ 5,215,574 $ $ 5,215,574
(8) Special mention
(9) Substandard - accruing
(9+) Non-accrual
Total mortgage finance $ $ $ $ $ $ $ 5,215,574 $ $ 5,215,574
Commercial real estate
(1-7) Pass $ 599,301 $ 889,603 $ 1,843,706 $ 885,913 $ 216,077 $ 704,288 $ 273,663 $ 18,085 $ 5,430,636
(8) Special mention 25,532 4,353 70,161 15,831 299 13,731 872 130,779
(9) Substandard - accruing 20,230 20,230
(9+) Non-accrual 85 20,637 13,915 34,637
Total commercial real estate $ 624,918 $ 893,956 $ 1,934,504 $ 901,744 $ 216,376 $ 752,164 $ 273,663 $ 18,957 $ 5,616,282
Consumer
(1-7) Pass $ 44,352 $ 28,289 $ 54,148 $ 75,924 $ 40,667 $ 99,471 $ 220,561 $ $ 563,412
(8) Special mention
(9) Substandard - accruing 1,000 1,000
(9+) Non-accrual 964 964
Total Consumer $ 44,352 $ 28,289 $ 54,148 $ 75,924 $ 40,667 $ 100,435 $ 221,561 $ $ 565,376
Total $ 2,305,541 $ 2,161,134 $ 3,438,876 $ 1,314,739 $ 334,555 $ 1,055,959 $ 11,901,022 $ 30,997 $ 22,542,823
Gross charge-offs $ 994 $ 7,543 $ 550 $ 4,037 $ 537 $ 8,784 $ 23,566 $ 44 $ 46,055
11

The following table details activity in the allowance for credit losses on loans. Allocation of a portion of the allowance to one category does not preclude its availability to absorb losses in other categories.
(in thousands) Commercial Mortgage
Finance
Commercial Real Estate Consumer Total
Three Months Ended March 31, 2025
Beginning balance $ 198,423 $ 2,755 $ 68,825 $ 1,706 $ 271,709
Provision for credit losses on loans 9,167 2,701 4,641 ( 42 ) 16,467
Charge-offs 10,197 500 10,697
Recoveries 483 413 4 900
Net charge-offs (recoveries) 9,714 87 ( 4 ) 9,797
Ending balance $ 197,876 $ 5,456 $ 73,379 $ 1,668 $ 278,379
Three Months Ended March 31, 2024
Beginning balance $ 171,437 $ 4,173 $ 71,829 $ 2,534 $ 249,973
Provision for credit losses on loans 19,976 1,825 2,786 166 24,753
Charge-offs 7,544 3,325 10,869
Recoveries 105 105
Net charge-offs (recoveries) 7,439 3,325 10,764
Ending balance $ 183,974 $ 5,998 $ 71,290 $ 2,700 $ 263,962
The Company recorded a $ 16.5 million provision for credit losses on loans for the three months ended March 31, 2025, compared to $ 24.8 million for the same period of 2024. The $ 16.5 million provision for credit losses on loans resulted primarily from an increase in criticized loans, $ 9.8 million in net charge-offs recorded during the three months ended March 31, 2025 and uncertainty in the economic outlook. Criticized loans totaled $ 762.9 million at March 31, 2025, compared to $714.0 million at December 31, 2024.
A loan is considered collateral-dependent when the borrower is experiencing financial difficulty and repayment is expected to be provided substantially through the operation or sale of the collateral. At March 31, 2025, the Company had $ 21.0 million in collateral-dependent commercial loans, collateralized by business assets, and $ 33.8 million in collateral-dependent commercial real estate loans, collateralized by real estate.
The table below provides an age analysis of gross loans held for investment:
(in thousands) 30-59 Days
Past Due
60-89 Days
Past Due
90 Days or More Past Due Total Past
Due
Non-accrual(1) Current Total Non-accrual With No Allowance
March 31, 2025
Commercial $ 1,298 $ 2,726 $ $ 4,024 $ 59,788 $ 11,340,482 $ 11,404,294 $ 5,689
Mortgage finance 4,725,541 4,725,541
Commercial real estate 5,103 791 5,894 33,777 5,784,316 5,823,987
Consumer 521,253 521,253
Total $ 6,401 $ 2,726 $ 791 $ 9,918 $ 93,565 $ 22,371,592 $ 22,475,075 $ 5,689
(1) As of March 31, 2025, $ 349,000 of non-accrual loans were earning interest income on a cash basis compared to $ 360,000 as of December 31, 2024. Additionally, $ 64,000 of interest income was recognized on non-accrual loans for the three months ended March 31, 2025 compared to $ 18,000 for the same period in 2024. Accrued interest of $ 7,000 and $ 487,000 was reversed during the three months ended March 31, 2025 and March 31, 2024, respectively.
12

Modifications to Borrowers Experiencing Financial Difficulty
The table below details gross loans held for investment as of March 31, 2025 and March 31, 2024 made to borrowers experiencing financial difficulty that were modified during the three months ended March 31, 2025 and March 31, 2024, by type of modification granted and the financial effect of those modifications:
Financial Statement Impact
($ in thousands) Payment
Deferral
Term
Extension
Payment
Deferral
and Term
Extension
Interest Rate
Reduction
and Term
Extension
Total Percentage of Loans Held for Investment Interest Rate Reduction Term Extension (in months) Payment Deferrals
Three Months Ended March 31, 2025
Commercial $ 1,817 $ $ 788 $ $ 2,605 0.01 % %
6 to 12
$ 135
Commercial real estate 18,163 18,163 0.08 % % 369
Total $ 19,980 $ $ 788 $ $ 20,768 0.09 %
Three Months Ended March 31, 2024
Commercial $ 11,575 $ 300 $ $ $ 11,875 0.06 % %
12
$ 3,650
Total $ 11,575 $ 300 $ $ $ 11,875 0.06 %
The table below details gross loans held for investment as of March 31, 2025 and March 31, 2024 that experienced a default during the periods presented subsequent to being granted a modification in the prior twelve months. Default is defined as movement to nonperforming status, foreclosure or charge-off, whichever occurs first.
(in thousands)
Payment
Deferral
Payment Deferral
and Term Extension
Total
Three Months Ended March 31, 2025
Commercial $ 2,996 $ $ 2,996
Commercial real estate 13,500 13,500
Total $ 2,996 $ 13,500 $ 16,496
Three Months Ended March 31, 2024
Commercial $ 3,129 $ 1,756 $ 4,885
Total $ 3,129 $ 1,756 $ 4,885
The table below provides an age analysis of gross loans held for investment as of March 31, 2025 and March 31, 2024 made to borrowers experiencing financial difficulty that were modified in the prior twelve months:
(in thousands) 30-89 Days
Past Due
90+ Days
Past Due
Non-Accrual Current Total
March 31, 2025
Commercial $ $ $ 9,567 $ 33,825 $ 43,392
Commercial real estate
31,663 15,831 47,494
Total $ $ $ 41,230 $ 49,656 $ 90,886
March 31, 2024
Commercial $ 259 $ $ 12,463 $ 34,253 $ 46,975
Commercial real estate
18,581 18,581
Total $ 259 $ $ 12,463 $ 52,834 $ 65,556

(5) Short-Term Borrowings and Long-Term Debt
The table below presents a summary of short-term borrowings:
(in thousands) March 31, 2025 December 31, 2024
Federal Home Loan Bank borrowings $ 750,000 $ 885,000
Total short-term borrowings $ 750,000 $ 885,000
13

The table below presents a summary of long-term debt:
(in thousands) March 31, 2025 December 31, 2024
Bank-issued 5.25 % fixed rate subordinated notes due 2026
174,783 174,717
Company-issued 4.00 % fixed rate subordinated notes due 2031
372,332 372,223
Trust preferred floating rate subordinated debentures due 2032 to 2036 113,406 113,406
Total long-term debt $ 660,521 $ 660,346
(6) Financial Instruments with Off-Balance Sheet Risk
The table below presents the Company’s financial instruments with off-balance sheet risk, as well as the activity in the allowance for off-balance sheet credit losses related to those financial instruments.
(in thousands) Commercial Mortgage
Finance
Commercial
Real Estate
Consumer Total
Three Months Ended March 31, 2025
Beginning balance $ 47,907 $ 23 $ 5,351 $ 51 $ 53,332
Provision for off-balance sheet credit losses 604 ( 2 ) ( 61 ) ( 8 ) 533
Ending balance $ 48,511 $ 21 $ 5,290 $ 43 $ 53,865
Three Months Ended March 31, 2024
Beginning balance $ 36,040 $ 6 $ 10,147 $ 169 $ 46,362
Provision for off-balance sheet credit losses ( 3,728 ) 28 ( 2,048 ) ( 5 ) ( 5,753 )
Ending balance $ 32,312 $ 34 $ 8,099 $ 164 $ 40,609
(in thousands) March 31, 2025 December 31, 2024
Commitments to extend credit - period end balance $ 10,005,653 $ 9,694,406
Standby letters of credit - period end balance 522,580 538,047
(7) Regulatory Ratios and Capital
The Company and the Bank are subject to various regulatory capital requirements administered by the federal banking agencies. Failure to meet minimum capital requirements can initiate certain mandatory (and possibly additional discretionary) actions by regulators that, if undertaken, could have a direct material adverse effect on the Company’s and the Bank’s financial statements. Under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Company and the Bank must meet specific capital guidelines that involve quantitative measures of the Company’s and the Bank’s assets, liabilities, and certain off-balance sheet items as calculated under regulatory accounting practices. The Company’s and the Bank’s capital amounts and classification are also subject to qualitative judgments by the regulators about components, risk weightings and other factors.
The Basel III Capital Rules adopted by U.S. federal banking agencies, among other things, (i) establish the capital measure called “Common Equity Tier 1” (“CET1”), (ii) specify that Tier 1 capital consists of CET1 and “Additional Tier 1 Capital” instruments meeting stated requirements, (iii) require that most deductions/adjustments to regulatory capital measures be made to CET1 and not to other components of capital and (iv) define the scope of the deductions/adjustments to the capital measures.
Additionally, the Basel III Capital Rules require that the Company maintain a 2.5 % capital conservation buffer comprised of CET1, with respect to each of CET1, Tier 1 and total capital to risk-weighted asset ratios. A financial institution with a conservation buffer of less than the required amount is subject to limitations on capital distributions, including dividend payments and stock repurchases, and certain discretionary bonus payments to executive officers. No dividends were declared or paid on the Company’s common stock during the three months ended March 31, 2025 or during 2024. On January 22, 2025, the Company’s board of directors authorized a new share repurchase program under which the Company may repurchase up to $ 200.0 million in shares of its outstanding common stock, which is set to expire January 31, 2026. During the three months ended March 31, 2025, the Company repurchased 396,106 shares of its common stock for an aggregate price, including excise tax expense, of $ 31.2 million, at a weighted average price of $ 78.25 per share.
Because the Bank had less than $ 15.0 billion in total consolidated assets as of December 31, 2009, it is allowed to continue to classify the trust preferred securities, all of which were issued prior to May 19, 2010, as Tier 1 capital.
At the beginning of each of the last five years of the life of the Bank-issued fixed rate subordinated notes due 2026, the amount that is eligible to be included in Tier 2 capital is reduced by 20% of the original amount of the notes (net of redemptions). In 2025, the amount of the notes that qualify as Tier 2 capital has been reduced by 100%.
14

The table below summarizes the Company’s and the Bank’s actual and required capital ratios under the Basel III Capital Rules and other standards. As shown in the table below, the Company’s and Bank’s capital ratios exceeded the regulatory definition of well capitalized as of March 31, 2025 and December 31, 2024.
March 31, 2025 December 31, 2024
(dollars in thousands) Minimum Capital Required(2) Capital Required to be Well Capitalized Capital Amount Ratio Capital Amount Ratio
The Company
CET1 capital (to risk-weighted assets) 7.00 % N/A $ 3,264,105 11.63 % $ 3,251,979 11.38 %
Tier 1 capital (to risk-weighted assets) 8.50 % 6.00 % 3,674,105 13.09 % 3,661,979 12.82 %
Total capital (to risk-weighted assets) 10.50 % 10.00 % 4,378,681 15.61 % 4,390,656 15.37 %
Tier 1 capital (to average assets)(1) 4.00 % N/A 3,674,105 11.77 % 3,661,979 11.33 %
The Bank
CET1 capital (to risk-weighted assets) 7.00 % 6.50 % $ 3,312,614 11.90 % $ 3,611,714 12.75 %
Tier 1 capital (to risk-weighted assets) 8.50 % 8.00 % 3,312,614 11.90 % 3,611,714 12.75 %
Total capital (to risk-weighted assets) 10.50 % 10.00 % 3,644,858 13.09 % 3,968,168 14.00 %
Tier 1 capital (to average assets)(1) 4.00 % 5.00 % 3,312,614 10.70 % 3,611,714 11.27 %
(1)    The Tier 1 capital ratio (to average assets) is not impacted by the Basel III Capital Rules; however, the Federal Reserve Board and the FDIC may require the Company and the Bank, respectively, to maintain a Tier 1 capital ratio (to average assets) above the required minimum.
(2)    Percentages represent the minimum capital ratios plus, as applicable, the fully phased-in 2.5% CET1 capital buffer under the Basel III Capital Rules.
(8) Stock-Based Compensation
The Company has long-term incentive plans under which stock-based compensation awards are granted to employees and directors by the Company’s board of directors or its designated committee. Grants are subject to vesting requirements and may include, among other things, nonqualified stock options, stock appreciation rights, restricted stock units (“RSUs”), restricted stock and performance units, or any combination thereof. On April 15, 2025, the Company’s stockholders approved the Texas Capital Bancshares, Inc. 2022 Long-Term Incentive Plan, as amended and restated, which increases shares authorized and available for grant by 1.1 million shares and extends the plan’s maturity date by two years .
The table below summarizes the Company’s stock-based compensation expense:
Three Months Ended March 31,
(in thousands) 2025 2024
Stock-settled awards:
RSUs $ 10,359 $ 8,026
Cash-settled units 2,391 508
Total $ 12,750 $ 8,534
(in thousands except period data) March 31, 2025
Unrecognized compensation expense related to unvested stock-settled awards $ 31,659
Weighted average period over which stock-settled awards expense is expected to be recognized, in years 2.1
Unrecognized compensation expense related to cash-settled units $ 25,252
Weighted average period over which cash-settled units expense is expected to be recognized, in years 2.5
(9) Fair Value Disclosures
The Company determines the fair market values of its assets and liabilities measured at fair value on a recurring and nonrecurring basis using the fair value hierarchy as prescribed in Accounting Standards Codification 820, Fair Value Measurements and Disclosures. See Note 1 - Operations and Summary of Significant Accounting Policies in the Company’s 2024 Form 10-K for information regarding the fair value hierarchy and a description of the methods and significant assumptions used by the Company in estimating its fair value disclosures for financial statements.
15

Assets and liabilities measured at fair value are as follows:
Fair Value Measurements Using
(in thousands) Level 1 Level 2 Level 3
March 31, 2025
Available-for-sale debt securities:(1)
U.S. Treasury securities $ 280,099 $ $
Residential mortgage-backed securities 3,146,131
Commercial mortgage-backed securities
240,554
CRT securities 11,594
Equity securities(1)(2) 55,551 16,128
Trading securities(1) 1,808
Loans held for investment(3) 29,175
Derivative assets(4) 39,542
Securities sold not yet purchased(5) 30,167
Derivative liabilities(4) 44,133
Non-qualified deferred compensation plan liabilities(6) 17,785
December 31, 2024
Available-for-sale debt securities:(1)
U.S. Treasury securities $ 277,285 $ $
Residential mortgage-backed securities 3,034,043
Commercial mortgage-backed securities
201,432
CRT securities 11,926
Equity securities(1)(2) 59,235 16,026
Loans held for investment(3) 35,318
Derivative assets(4) 23,202
Securities sold not yet purchased(5) 33,705
Derivative liabilities(4) 57,906
Non-qualified deferred compensation plan liabilities(6) 19,109
(1) Available-for-sale debt securities, equity securities and trading securities are measured at fair value on a recurring basis, generally monthly.
(2) Equity securities consist of investments that qualify for consideration under the regulations implementing the Community Reinvestment Act and investments in exchange traded funds.
(3) Includes certain collateral-dependent loans held for investment for which a specific allocation of the allowance for credit losses is based upon the fair value of the loan’s underlying collateral. These loans held for investment are measured on a nonrecurring basis, generally annually or more often as warranted by market and economic conditions.
(4) Derivative assets and liabilities are measured at fair value on a recurring basis, generally quarterly.
(5) Securities sold not yet purchased are measured at fair value on a recurring basis, generally monthly.
(6) Non-qualified deferred compensation plan liabilities represent the fair value of the obligation to the employee, which generally corresponds to the fair value of the invested assets, and are measured at fair value on a recurring basis, generally monthly.
Level 3 Valuations
The following table presents a reconciliation of the level 3 fair value category measured at fair value on a recurring basis:
Net Gains/(Losses)
(in thousands) Balance at Beginning of Period Purchases / Additions Sales / Reductions Realized Unrealized Balance at End of Period
Three Months Ended March 31, 2025
Available-for-sale debt securities:(1)
CRT securities $ 11,926 $ $ ( 301 ) $ $ ( 31 ) $ 11,594
Three Months Ended March 31, 2024
Available-for-sale debt securities:(1)
CRT securities $ 11,995 $ $ ( 209 ) $ $ 475 $ 12,261
(1) Unrealized gains/(losses) on available-for-sale debt securities are recorded in AOCI . Realized gains/(losses) are recorded in other non-interest income on the consolidated statements of income and other comprehensive income/(loss).
CRT securities
The fair value of CRT securities is based on a discounted cash flow model, which utilizes Level 3 inputs, the most significant of which were a discount rate and weighted-average life. At March 31, 2025, the discount rates utilized ranged from 4.90 % to
16

6.20 % and the weighted-average life ranged from 4.31 years to 6.41 years. On a combined amortized cost weighted-average basis a discount rate of 5.42 % and a weighted-average life of 5.15 years were utilized to determine the fair value of these securities at March 31, 2025. At December 31, 2024, the combined weighted-average discount rate and weighted-average life utilized were 5.63 % and 5.35 years, respectively.
Loans held for investment
Certain collateral-dependent loans held for investment are reported at fair value when, based upon an individual evaluation, the specific allocation of the allowance for credit losses that is deducted from the loan's amortized cost is based upon the fair value of the loan's underlying collateral. The $ 29.2 million fair value of loans held for investment at March 31, 2025 reported above includes impaired loans with a carrying value of $ 54.8 million that were reduced by specific allowance allocations totaling $ 25.6 million based on collateral valuations utilizing Level 3 inputs. The $ 35.3 million fair value of loans held for investment at December 31, 2024 reported above includes impaired loans with a carrying value of $ 63.6 million that were reduced by specific allowance allocations totaling $ 28.3 million based on collateral valuations utilizing Level 3 inputs.
Fair Value of Financial Instruments
A summary of the carrying amounts and estimated fair values of financial instruments is as follows:
Carrying
Amount
Estimated Fair Value
(in thousands) Total Level 1 Level 2 Level 3
March 31, 2025
Financial assets:
Cash and cash equivalents $ 3,802,473 $ 3,802,473 $ 3,802,473 $ $
Available-for-sale debt securities 3,678,378 3,678,378 280,099 3,386,685 11,594
Held-to-maturity debt securities 779,354 685,662 685,662
Equity securities 71,679 71,679 55,551 16,128
Trading securities 1,808 1,808 1,808
Loans held for investment, net 22,101,405 22,044,077 22,044,077
Derivative assets 39,542 39,542 39,542
Financial liabilities:
Total deposits 26,053,034 26,056,248 26,056,248
Short-term borrowings 750,000 750,000 750,000
Long-term debt 660,521 628,824 628,824
Securities sold not yet purchased 30,167 30,167 30,167
Derivative liabilities 44,133 44,133 44,133
December 31, 2024
Financial assets:
Cash and cash equivalents $ 3,188,808 $ 3,188,808 $ 3,188,808 $ $
Available-for-sale debt securities 3,524,686 3,524,686 277,285 3,235,475 11,926
Held-to-maturity debt securities 796,168 678,174 678,174
Equity securities 75,261 75,261 59,235 16,026
Loans held for investment, net 22,178,357 22,115,585 22,115,585
Derivative assets 23,202 23,202 23,202
Financial liabilities:
Total deposits 25,238,599 25,245,009 25,245,009
Short-term borrowings 885,000 885,000 885,000
Long-term debt 660,346 622,713 622,713
Securities sold not yet purchased 33,705 33,705 33,705
Derivative liabilities 57,906 57,906 57,906
17

(10) Derivative Financial Instruments
The notional amounts and estimated fair values of derivative positions outstanding are presented in the following table.
March 31, 2025 December 31, 2024
Estimated Fair Value Estimated Fair Value
(in thousands) Notional
Amount
Asset Derivative Liability Derivative Notional
Amount
Asset Derivative Liability Derivative
Derivatives designated as hedges
Cash flow hedges:
Interest rate contracts:
Swaps hedging loans $ 2,900,000 $ 1,977 $ 15,106 $ 2,600,000 $ 254 $ 23,265
Non-hedging derivatives
Customer-initiated and other derivatives:
Foreign currency forward contracts 288,229 5,926 5,738 485,948 5,462 5,299
Interest rate contracts:
Swaps 6,274,509 40,507 40,507 6,273,301 45,771 45,771
Caps and floors written 2,133,194 3,154 3,702 970,451 1,066 2,529
Caps and floors purchased 2,133,194 3,702 3,145 970,451 2,529 1,066
Forward contracts 28,877,726 50,431 49,207 20,237,917 41,896 41,035
Gross derivatives 105,697 117,405 96,978 118,965
Netting adjustment - offsetting derivative assets/liabilities ( 47,941 ) ( 47,941 ) ( 44,097 ) ( 44,097 )
Netting adjustment - cash collateral received/posted ( 18,214 ) ( 25,331 ) ( 29,679 ) ( 16,962 )
Net derivatives included on the consolidated balance sheets $ 39,542 $ 44,133 $ 23,202 $ 57,906
The Company’s credit exposure on derivative instruments is limited to the net favorable value and interest payments by each counterparty. In some cases, collateral may be required from the counterparties involved if the net value of the derivative instruments exceeds a nominal amount. The Company’s credit exposure associated with these instruments, net of any collateral pledged, was approximately $ 39.5 million at March 31, 2025 and approximately $ 23.2 million at December 31, 2024. Collateral levels are monitored and adjusted on a regular basis for changes in the value of derivative instruments. At March 31, 2025, the Company had $ 45.6 million in cash collateral pledged to counterparties included in interest bearing cash and cash equivalents on the consolidated balance sheet and $ 19.3 million in cash collateral received from counterparties included in interest bearing deposits on the consolidated balance sheet. The comparative amounts at December 31, 2024, were $ 71.3 million in cash collateral pledged to counterparties and $ 31.0 million cash collateral received from counterparties.
The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 12 risk participation agreements where it acts as a participant bank with a notional amount of $ 193.1 million at March 31, 2025, compared to 17 risk participation agreements with a notional amount of $ 228.6 million at December 31, 2024. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 2.0 million at March 31, 2025 and $ 4.1 million at December 31, 2024. The fair value of these exposures was insignificant to the consolidated financial statements at both March 31, 2025 and December 31, 2024. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 29 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 383.5 million at March 31, 2025, compared to 25 agreements having a notional amount of $ 349.5 million at December 31, 2024.
Derivatives Designated as Cash Flow Hedges
The Company enters into interest rate derivative contracts that are designated as qualifying cash flow hedges to hedge the exposure to variability in expected future cash flows attributable to changes in a contractually specified interest rate.
During the three months ended March 31, 2025, the Company recorded $ 658,000 in unrealized gains to adjust its cash flow hedges to fair value, which was recorded net of tax to AOCI, and reclassified $ 8.7 million from AOCI as a decrease to interest income on loans. Based on current market conditions, the Company estimates that during the next 12 months, an additional $ 11.2 million related to active and terminated hedges will be reclassified from AOCI as a decrease to interest income. As of March 31, 2025, the maximum length of time over which forecasted transactions are hedged is 2.42 years.
18

(11) Accumulated Other Comprehensive Income
The following table provides the change in AOCI by component:
(in thousands) Cash Flow Hedges Available-for-Sale Securities Held-to-Maturity Securities Total
Three Months Ended March 31, 2025
Beginning balance $ ( 15,275 ) $ ( 131,531 ) $ ( 36,301 ) $ ( 183,107 )
Change in unrealized gain/(loss) 658 49,621 50,279
Amounts reclassified into net income 8,714 1,645 10,359
Total other comprehensive income
9,372 49,621 1,645 60,638
Income tax expense
2,117 11,204 372 13,693
Total other comprehensive income, net of tax
7,255 38,417 1,273 46,945
Ending balance $ ( 8,020 ) $ ( 93,114 ) $ ( 35,028 ) $ ( 136,162 )
Three Months Ended March 31, 2024
Beginning balance $ ( 45,749 ) $ ( 273,806 ) $ ( 42,449 ) $ ( 362,004 )
Change in unrealized gain/(loss) ( 27,873 ) ( 14,470 ) ( 42,343 )
Amounts reclassified into net income 18,006 1,702 19,708
Total other comprehensive income/(loss) ( 9,867 ) ( 14,470 ) 1,702 ( 22,635 )
Income tax expense/(benefit) ( 2,072 ) ( 3,038 ) 357 ( 4,753 )
Total other comprehensive income/(loss), net of tax ( 7,795 ) ( 11,432 ) 1,345 ( 17,882 )
Ending balance $ ( 53,544 ) $ ( 285,238 ) $ ( 41,104 ) $ ( 379,886 )
(12) New Accounting Standards
Accounting Standards Update 2025-01 “Income Statement Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date” (“ASU 2025-01”) clarifies the effective date of Accounting Standards Update 2024-03 “Income Statement Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses” (“ASU 2024-03”) to stipulate that ASU 2024-03 is effective for public business entities for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027, with early adoption permitted. ASU 2024-03 will be effective for the Company beginning January 1, 2027 for the Company’s annual financial statements on Form 10-K and January 1, 2028 for the Company’s quarterly financial statements on Form 10-Q and is not expected to have a significant impact on the Company’s financial statements.
Accounting Standards Update 2025-02 “Liabilities (405): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 122” (“ASU 2025-02”) amends the Accounting Standards Codification to remove the text of SEC Staff Accounting Bulletin (“SAB”) 121 “Accounting for Obligations to Safeguard Crypto-Assets an Entity Holds for its Platform Users” as it has been rescinded by the issuance of SAB 122. ASU 2025-02 is effective immediately and is not expected to have an impact on the Company’s financial statements.
19

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of the Company’s financial condition and results of operations for the three months ended March 31, 2025 and 2024 should be read in conjunction with its audited consolidated financial statements and the related notes to the consolidated financial statements included in 2024 Form 10-K. Operating results for the three months ended March 31, 2025 are not necessarily indicative of the results for the year ending December 31, 2025 or any future period.
Forward-Looking Statements
This report contains “forward-looking statements” within the meaning of and pursuant to the Private Securities Litigation Reform Act of 1995 regarding, among other things, the Company’s financial condition, results of operations, business plans and future performance. These statements are not historical in nature and may often be identified by the use of words such as “believes,” “projects,” “expects,” “may,” “estimates,” “should,” “plans,” “targets,” “intends” “could,” “would,” “anticipates,” “potential,” “confident,” “optimistic” or the negative thereof, or other variations thereon, or comparable terminology, or by discussions of strategy, objectives, estimates, trends, guidance, expectations and future plans.
Because forward-looking statements relate to future results and occurrences, they are subject to inherent and various uncertainties, risks, and changes in circumstances that are difficult to predict, may change over time, are based on management’s expectations and assumptions at the time the statements are made and are not guarantees of future results. Numerous risks and other factors, many of which are beyond management’s control, could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. While there can be no assurance that any list of risks is complete, important risks and other factors that could cause actual results to differ materially from those contemplated by forward-looking statements include, but are not limited to, economic or business conditions in Texas, the United States, or globally that impact TCBI or its customers; negative credit quality developments arising from the foregoing or other factors, including recent trade policies and their impact on our customers; increased or expanded competition from banks and other financial service providers in TCBI’s markets; TCBI’s ability to effectively manage its liquidity and maintain adequate regulatory capital to support its businesses; TCBI’s ability to pursue and execute upon growth plans, whether as a function of capital, liquidity, or other limitations; TCBI’s ability to successfully execute its business strategy, including its strategic plan and developing and executing new lines of business and new products and services and potential strategic acquisitions; the extensive regulations to which TCBI is subject and its ability to comply with applicable governmental regulations, including legislative and regulatory changes; TCBI’s ability to effectively manage information technology systems, including third party vendors, cyber or data privacy incidents, or other failures, disruptions or security breaches; TCBI’s ability to use technology to provide products and services to its customers; risks related to the development and use of AI; changes in interest rates, including the impact of interest rates on TCBI’s securities portfolio and funding costs, as well as related balance sheet implications stemming from the fair value of our assets and liabilities; the effectiveness of TCBI’s risk management processes, strategies and monitoring; fluctuations in commercial and residential real estate values, especially as they relate to the value of collateral supporting TCBI’s loans; the failure to identify, attract, and retain key personnel and other employees; adverse developments in the banking industry and the potential impact of such developments on customer confidence, liquidity and regulatory responses to these developments, including in the context of regulatory examinations and related findings and actions; negative press and social media attention with respect to the banking industry or TCBI, in particular; claims, litigation or regulatory investigations and actions that TCBI may become subject to; severe weather, natural disasters, climate change, acts of war, terrorism, global conflict, or other external events, as well as related legislative and regulatory initiatives; and the risks and factors more fully described in TCBI’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other documents and filings with the SEC. The information contained in this communication speaks only as of its date. Except to the extent required by applicable law or regulation, we disclaim any obligation to update such factors or to publicly announce the results of any revisions to any of the forward-looking statements included herein to reflect future events or developments.
20

Results of Operations
Selected income statement data and key performance indicators are presented in the table below:
Three Months Ended March 31,
(dollars in thousands except per share data) 2025 2024
Net interest income $ 236,034 $ 215,009
Provision for credit losses 17,000 19,000
Non-interest income 44,444 41,319
Non-interest expense 203,020 202,393
Income before income taxes
60,458 34,935
Income tax expense
13,411 8,793
Net income
47,047 26,142
Preferred stock dividends 4,313 4,313
Net income available to common stockholders
$ 42,734 $ 21,829
Basic earnings per common share
$ 0.93 $ 0.46
Diluted earnings per common share
$ 0.92 $ 0.46
Net interest margin 3.19 % 3.03 %
Return on average assets (“ROA”) 0.61 % 0.36 %
Return on average common equity (“ROE”) 5.56 % 3.03 %
Efficiency ratio(1) 72.4 % 79.0 %
Non-interest income to average earning assets 0.60 % 0.59 %
Non-interest expense to average earning assets 2.75 % 2.89 %
(1)    Non-interest expense divided by the sum of net interest income and non-interest income.
Three months ended March 31, 2025 compared to three months ended March 31, 2024
The Company reported net income of $47.0 million and net income available to common stockholders of $42.7 million for the three months ended March 31, 2025, compared to net income of $26.1 million and net income available to common stockholders of $21.8 million for the same period in 2024. On a fully diluted basis, earnings per common share was $0.92 for the three months ended March 31, 2025, compared to $0.46 for the same period in 2024. ROE was 5.56% and ROA was 0.61% for the three months ended March 31, 2025, compared to 3.03% and 0.36%, respectively, for the same period in 2024. The increase in net income for the three months ended March 31, 2025 compared to the same period in 2024 resulted primarily from an increase in net interest income.
Details of the changes in the various components of net income are discussed below.

21

Taxable Equivalent Net Interest Income Analysis - Year to Date(1)
Three Months Ended March 31, 2025 Three Months Ended March 31, 2024
(dollars in thousands) Average
Balance
Revenue /
Expense
Yield /
Rate
Average
Balance
Revenue /
Expense
Yield /
Rate
Assets
Investment securities(2) $ 4,463,876 $ 46,565 4.10 % $ 4,299,368 $ 32,144 2.77 %
Interest bearing cash and cash equivalents 4,255,796 46,574 4.44 % 4,051,627 54,355 5.40 %
Loans held for sale 335 2 2.97 % 51,164 1,184 9.31 %
Loans held for investment, mortgage finance 3,972,106 38,527 3.93 % 3,517,707 31,455 3.60 %
Loans held for investment(3) 17,527,070 296,091 6.85 % 16,522,089 298,306 7.26 %
Less: Allowance for credit losses on loans 272,758 % 249,936 %
Loans held for investment, net
21,226,418 334,618 6.39 % 19,789,860 329,761 6.70 %
Total earning assets 29,946,425 427,759 5.76 % 28,192,019 417,444 5.88 %
Cash and other assets 1,157,184 1,058,463
Total assets $ 31,103,609 $ 29,250,482
Liabilities and Stockholders’ Equity
Transaction deposits $ 2,163,250 $ 13,908 2.61 % $ 2,006,493 $ 16,858 3.38 %
Savings deposits 13,357,243 133,577 4.06 % 11,409,677 136,790 4.82 %
Time deposits 2,329,384 27,451 4.78 % 1,719,325 21,952 5.14 %
Total interest bearing deposits 17,849,877 174,936 3.97 % 15,135,495 175,600 4.67 %
Short-term borrowings 751,500 8,246 4.45 % 912,088 12,783 5.64 %
Long-term debt 660,445 8,073 4.96 % 859,509 13,986 6.54 %
Total interest bearing liabilities 19,261,822 191,255 4.03 % 16,907,092 202,369 4.81 %
Non-interest bearing deposits 7,875,244 8,637,775
Other liabilities 552,154 509,286
Stockholders’ equity 3,414,389 3,196,329
Total liabilities and stockholders’ equity $ 31,103,609 $ 29,250,482
Net interest income $ 236,504 $ 215,075
Net interest margin 3.19 % 3.03 %
(1) Taxable equivalent rates used where applicable.
(2) Yields on investment securities are calculated using available-for-sale securities at amortized cost.
(3) Average balances include non-accrual loans.
22

Volume/Rate Analysis
The following table presents the changes in taxable equivalent net interest income and identifies the changes due to differences in the average volume of earning assets and interest bearing liabilities and the changes due to differences in the average interest rate on those assets and liabilities.
Three Months Ended March 31, Three Months Ended March 31,
2025/2024 2024/2023
Net
Change
Change Due To(1) Net
Change
Change Due To(1)
(in thousands) Volume Yield/Rate(2) Volume Yield/Rate(2)
Interest income
Investment securities $ 14,421 $ 1,133 $ 13,288 $ 6,852 $ 1,376 $ 5,476
Interest bearing cash and cash equivalents (7,781) 2,741 (10,522) (8,081) (16,973) 8,892
Loans held for sale (1,182) (1,177) (5) 246 168 78
Loans held for investment, mortgage finance 7,072 4,067 3,005 (5,964) 2,660 (8,624)
Loans held for investment (2,215) 18,141 (20,356) 39,066 15,514 23,552
Total interest income 10,315 24,905 (14,590) 32,119 2,745 29,374
Interest expense
Transaction deposits (2,950) 1,317 (4,267) 13,005 6,164 6,841
Savings deposits (3,213) 23,340 (26,553) 31,083 2,046 29,037
Time deposits 5,499 7,796 (2,297) 11,418 2,152 9,266
Short-term borrowings (4,537) (2,252) (2,285) (1,961) (3,967) 2,006
Long-term debt (5,913) (3,237) (2,676) (997) (1,175) 178
Total interest expense (11,114) 26,964 (38,078) 52,548 5,220 47,328
Net interest income $ 21,429 $ (2,059) $ 23,488 $ (20,429) $ (2,475) $ (17,954)
(1) Yield/rate and volume variances are allocated to yield/rate.
(2) Taxable equivalent rates used where applicable assuming a 21% tax rate.

Net Interest Income
Net interest income was $236.0 million for the three months ended March 31, 2025, compared to $215.0 million for the same period in 2024. The increase was primarily due to an increase in average total loans held for investment and a decrease in funding costs, partially offset by an increase in average interest bearing liabilities and a decrease in earning asset yields.
Average earning assets increased $1.8 billion for the three months ended March 31, 2025, compared to the same period in 2024, which included increases of $1.5 billion in average total loans held for investment, $164.5 million in average investment securities and $204.2 million in average interest bearing cash and cash equivalents. Average interest bearing liabilities increased $2.4 billion for the three months ended March 31, 2025, compared to the same period in 2024, primarily due to an increase of $2.7 billion in average interest bearing deposits, partially offset by decreases of $160.6 million in average short-term borrowings and $199.1 million in average long-term debt. Average non-interest bearing deposits for the three months ended March 31, 2025 decreased to $7.9 billion from $8.6 billion for the same period in 2024.
Net interest margin for the three months ended March 31, 2025 was 3.19%, compared to 3.03% for the same period of 2024. The increase was primarily due to a decrease in the cost of interest bearing deposits, partially offset by lower earning asset yields, compared to the same period in 2024.
The yield on total loans held for investment decreased to 6.39% for the three months ended March 31, 2025, compared to 6.70% for the same period in 2024, and the yield on earning assets decreased to 5.76% for the three months ended March 31, 2025, compared to 5.88% for the same period in 2024. Total cost of deposits decreased to 2.76% for the three months ended March 31, 2025 from 2.97% for the same period in 2024 and total funding costs, including non-interest bearing deposits and stockholders' equity, decreased to 2.54% for the three months ended March 31, 2025, compared to 2.83% for the same period in 2024.
23

Non-interest Income
Three Months Ended March 31,
(in thousands) 2025 2024
Service charges on deposit accounts $ 7,840 $ 6,339
Wealth management and trust fee income 3,964 3,567
Brokered loan fees 1,949 1,911
Investment banking and advisory fees 16,478 18,424
Trading income 5,939 4,712
Other 8,274 6,366
Total non-interest income $ 44,444 $ 41,319
Non-interest income increased $3.1 million during the three months ended March 31, 2025, compared to the same period in 2024, primarily due to increases in service charges on deposit accounts, trading income and other non-interest income, partially offset by a decrease in investment banking and advisory fees.
Non-interest Expense
Three Months Ended March 31,
(in thousands) 2025 2024
Salaries and benefits $ 131,641 $ 128,727
Occupancy expense 10,844 9,737
Marketing 5,009 6,036
Legal and professional 14,989 16,195
Communications and technology 23,642 21,114
Federal Deposit Insurance Corporation (“FDIC”) insurance assessment 5,341 8,421
Other 11,554 12,163
Total non-interest expense $ 203,020 $ 202,393
Non-interest expense increased $627,000 during the three months ended March 31, 2025, compared to the same period in 2024. The increase was primarily due to increases in salaries and benefits and communications and technology expense, partially offset by a decrease in FDIC expense. The three months ended March 31, 2024 included $3.0 million in additional FDIC special assessment expense.
Analysis of Financial Condition
Loans Held for Investment
The following table summarizes the Company’s loans held for investment by portfolio segment. See Note 1 - Operations and Summary of Significant Accounting Policies in the 2024 Form 10-K for details of these portfolio segments.
(in thousands) March 31, 2025 December 31, 2024
Commercial $ 11,404,294 $ 11,145,591
Mortgage finance 4,725,541 5,215,574
Commercial real estate 5,823,987 5,616,282
Consumer
521,253 565,376
Gross loans held for investment
22,475,075 22,542,823
Unearned income (net of direct origination costs)
(95,291) (92,757)
Total loans held for investment $ 22,379,784 $ 22,450,066
Total loans held for investment were $22.4 billion at March 31, 2025, an increase of $70.3 million from December 31, 2024, as increases in commercial and commercial real estate loans were partially offset by a decrease in mortgage finance loans. Mortgage finance loans include legal ownership interests in mortgage loans that the Company purchases from unaffiliated mortgage originators, either directly or through a special purpose entity structure, that are typically sold within 10 to 20 days and represent 21% and 23% of gross loans held for investment at March 31, 2025 and December 31, 2024, respectively. Volumes fluctuate based on the level of market demand for the product and the number of days between purchase and sale of the loans, which can be affected by changes in overall market interest rates, and tend to peak at the end of each month.
The Company originates a substantial majority of all loans held for investment. The Company also participates in shared national credits, both as a participant and as an agent. As of March 31, 2025, the Company had $5.8 billion in shared national credits, $1.0 billion of which the Company administered as agent. All syndicated loans, whether the Company acts as agent or
24

participant, are underwritten to the same standards as all other loans the Company originates. As of March 31, 2025, approximately $34.0 million of the Company’s shared national credits were on non-accrual.
Portfolio Concentrations
Although more than 50% of the Company’s total loan exposure is outside of Texas and more than 50% of deposits are sourced outside of Texas, Texas concentration remains significant. As of March 31, 2025, a majority of the loans held for investment, excluding mortgage finance and other national lines of business, were to businesses with headquarters or operations in Texas. This geographic concentration subjects the Company’s loan portfolio to the general economic conditions within this state. The risks created by this concentration have been considered by management in determining the appropriateness of the allowance for credit losses.
Non-performing Assets
Non-performing assets include non-accrual loans and leases, and repossessed assets. The table below summarizes non-accrual loans by portfolio segment and by type of property securing the credit.
(dollars in thousands) March 31, 2025 December 31, 2024
Non-accrual loans held for investment
Commercial:
Business assets $ 52,318 $ 64,481
Accounts receivable and inventory 3,914 6,315
Machinery and equipment
2,333 2,729
Unsecured 60
Highly liquid assets 1,223 1,340
Other 639
Total commercial 59,788 75,564
Commercial real estate:
Industrial buildings
20,277 20,637
Office buildings
13,500 14,000
Hotel/motel buildings
Total commercial real estate 33,777 34,637
Consumer:
Single family residences 964
Total consumer 964
Total non-accrual loans held for investment 93,565 111,165
Non-accrual loans held for sale
Other real estate owned (“OREO”)
Total non-performing assets $ 93,565 $ 111,165
Non-accrual loans held for investment to total loans held for investment 0.42 % 0.50 %
Total non-performing assets to total assets 0.30 % 0.36 %
Allowance for credit losses on loans to non-accrual loans held for investment 3.0x 2.4x
Loans held for investment past due 90 days and accruing $ 791 $ 4,265
Loans held for investment past due 90 days to total loans held for investment % 0.02 %
Loans held for sale past due 90 days and accruing $ $
Summary of Credit Loss Experience
The provision for credit losses, comprised of a provision for loans and off-balance sheet credit losses, is a charge to earnings to maintain the allowance for credit losses at a level consistent with management’s assessment of expected losses at each balance sheet date.
The Company recorded a provision for credit losses of $17.0 million for the three months ended March 31, 2025, compared to a provision of $19.0 million for the three months ended March 31, 2024. The provision for credit losses for the three months ended March 31, 2025 reflects an increase in criticized loans, $9.8 million in net charge-offs recorded during the three months ended March 31, 2025 and uncertainty in the economic outlook. Criticized loans totaled $762.9 million at March 31, 2025, compared to $714.0 million at December 31, 2024.
25

The table below presents key metrics related to the Company’s credit loss experience:
March 31, 2025 March 31, 2024
Allowance for credit losses on loans to total loans held for investment 1.24 % 1.27 %
Allowance for credit losses on loans to average total loans held for investment(1) 1.29 % 1.32 %
Total allowance for credit losses to total loans held for investment 1.48 % 1.46 %
Total provision for credit losses to average total loans held for investment(1)(2) 0.32 % 0.38 %
(1) Ratios are calculated using average balance for the three months ended March 31, 2025 and 2024, respectively.
(2) Ratios are annualized utilizing provision for credit losses for the three months ended March 31, 2025 and 2024, respectively.
The table below details net charge-offs/(recoveries) as a percentage of average total loans by portfolio segment:
Three Months Ended March 31,
2025 2024
(dollars in thousands) Net
Charge-offs
Net Charge-offs
to Average
Loans(1)
Net
Charge-offs
Net Charge-offs
to Average
Loans(1)
Commercial $ 9,714 0.35 % $ 7,439 0.29 %
Mortgage finance % %
Commercial real estate 87 0.01 % 3,325 0.24 %
Consumer (4) % %
Total $ 9,797 0.18 % $ 10,764 0.22 %
(1) Ratios are annualized utilizing net charge-offs for the three months ended March 31, 2025 and 2024, respectively.
Liquidity and Capital Resources
Liquidity
In general terms, liquidity is a measurement of the Company’s ability to meet its cash needs. The Company’s objectives in managing its liquidity are to maintain the ability to meet loan commitments, repurchase investment securities and repay deposits and other liabilities in accordance with their terms, without an adverse impact on current or future earnings. The Company’s liquidity strategy is guided by policies, formulated and monitored by senior management and the Asset and Liability Management Committee (“ALCO”), which take into account the demonstrated marketability of the Company’s assets, the sources and stability of its funding and the level of unfunded commitments. The Company regularly evaluates all of its various funding sources with an emphasis on accessibility, stability, reliability and cost-effectiveness. The Company’s principal source of funding is customer deposits, supplemented by short-term borrowings, primarily from federal funds purchased and Federal Home Loan Bank (“FHLB”) borrowings, which are generally used to fund mortgage finance loans, and long-term debt. The Company also relies on the availability of the mortgage secondary market provided by Ginnie Mae and government sponsored entities to support the liquidity of mortgage finance loans.
The following table summarizes the Company’s interest bearing cash and cash equivalents:
(dollars in thousands) March 31, 2025 December 31, 2024
Interest bearing cash and cash equivalents $ 3,600,969 $ 3,012,307
Interest bearing cash and cash equivalents as a percent of:
Total loans held for investment 16.1 % 13.4 %
Total earning assets 11.9 % 10.2 %
Total deposits 13.8 % 11.9 %
The Company aims to obtain as much of its funding as possible from customer deposits, which are generated through digital acquisition or as a result of development of long-term customer relationships, with a significant focus on treasury management products. In addition, the Company also has access to deposits through brokered channels. The following table summarizes period-end total deposits:
March 31, 2025 December 31, 2024
(dollars in thousands) Balance % of Total Balance % of Total
Customer deposits $ 25,657,040 98.5 % $ 24,704,091 97.9 %
Brokered deposits 395,994 1.5 % 534,508 2.1 %
Total deposits $ 26,053,034 100.0 % $ 25,238,599 100.0 %
26

Estimated uninsured deposits, including accrued interest, were 41% of total deposits at both March 31, 2025 and December 31, 2024. The uninsured amounts are estimated based on the methodologies and assumptions used for the Bank’s regulatory reporting requirements.
The Company has short-term borrowing sources available to supplement deposits and meet its funding needs. Such borrowings are generally used to fund mortgage finance loans, due to their liquidity, short duration and interest spreads available. These borrowing sources include federal funds purchased from downstream correspondent bank relationships (which consist of banks that are smaller than the Bank) and from upstream correspondent bank relationships (which consist of banks that are larger than the Bank), customer repurchase agreements and advances from the FHLB and the Federal Reserve. The following table summarizes short-term borrowings, all of which mature within one year:
(in thousands) March 31, 2025 December 31, 2024
FHLB borrowings $ 750,000 $ 885,000
Total short-term and other borrowings $ 750,000 $ 885,000
The following table summarizes the Company’s short-term borrowing capacities net of balances outstanding:
(in thousands) March 31, 2025 December 31, 2024
FHLB borrowing capacity relating to loans and pledged securities $ 3,635,441 $ 4,664,703
FHLB borrowing capacity relating to unencumbered securities 4,351,533 4,189,993
Total FHLB borrowing capacity(1) $ 7,986,974 $ 8,854,696
Unused federal funds lines available from commercial banks $ 1,375,000 $ 1,370,000
Unused Federal Reserve borrowings capacity $ 6,486,275 $ 5,436,652
Unused revolving line of credit(2) $ 75,000 $ 75,000
(1) FHLB borrowings are collateralized by a blanket floating lien on certain real estate secured loans, mortgage finance loans and certain pledged securities.
(2) Unsecured revolving, non-amortizing line of credit with maturity date of February 8, 2026. Proceeds may be used for general corporate purposes, including funding regulatory capital infusions into the Bank. The loan agreement contains customary financial covenants and restrictions. No borrowings were made against this line of credit during the three months ended March 31, 2025 or 2024.
The Company has long-term debt outstanding of $660.5 million as of March 31, 2025, comprised of trust preferred securities and subordinated notes with maturity dates ranging from January 2026 to December 2036. See Note 5 - Short-Term Borrowings and Long-Term Debt in the accompanying notes to the consolidated financial statements included elsewhere in this report for additional information. The Company may consider raising additional capital, if needed, in public or private offerings of debt or equity securities to supplement deposits and meet its long-term funding needs.
As the Company is a holding company and is a separate operating entity from the Bank, the Company’s primary sources of liquidity are dividends received from the Bank and borrowings from outside sources. Banking regulations may limit the amount of dividends that may be paid by the Bank. See Note 7 - Regulatory Ratios and Capital in the accompanying notes to the consolidated financial statements included elsewhere in this report for additional information regarding dividend restrictions and “ Liquidity Risks ” included in Part I, Item 1A. Risk Factors of the 2024 Form 10-K.
Periodically, based on market conditions and other factors, and subject to compliance with applicable laws and regulations and the terms of its existing indebtedness, the Company may repay, repurchase, exchange or redeem outstanding indebtedness, or otherwise enter into transactions regarding debt or capital structure. For example, the Company periodically evaluates and may engage in liability management transactions, including repurchases or redemptions of outstanding subordinated notes, which may be funded by the issuance of, or exchanges of, newly issued unsecured borrowings to actively manage the debt maturity profile and interest cost.
Capital Resources
The Company’s equity capital averaged $3.4 billion for the three months ended March 31, 2025 compared to $3.2 billion for the same period in 2024. The Company has not paid any cash dividends on common stock since operations commenced and has no plans to do so in the foreseeable future.
On January 22, 2025, the Company’s board of directors authorized a share repurchase program under which the Company may repurchase up to $200.0 million in shares of its outstanding common stock, excluding the effect of excise tax expense incurred on net stock repurchases. The share repurchase program expires on January 31, 2026, but may be suspended or discontinued at any time. Remaining repurchase authorization under the January 17, 2024 share repurchase program was terminated upon authorization of this new program. During the three months ended March 31, 2025, the Company repurchased 396,106 shares of its common stock for an aggregate purchase price, including excise tax expense, of $31.2 million, at a weighted average price of $78.25 per share.
27

Any repurchases under the Company’s repurchase program will be made in accordance with applicable securities laws from time to time in open market or private transactions. The extent to which the Company repurchases shares, and the timing of such repurchases, will be at management’s discretion and will depend upon a variety of factors, including market conditions, the Company’s capital position and amount of retained earnings, regulatory requirements and other considerations.
For additional information on the Company’s capital and stockholders’ equity, see Note 7 - Regulatory Ratios and Capital, in the accompanying notes to the consolidated financial statements included elsewhere in this report.
Critical Accounting Estimates
SEC guidance requires disclosure of “critical accounting estimates.” The SEC defines “critical accounting estimates” as those estimates made in accordance with generally accepted accounting principles that involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on the financial condition or results of operations of the registrant.
The Company follows financial accounting and reporting policies that are in accordance with accounting principles generally accepted in the United States. The more significant of these policies are summarized in Note 1 - Operations and Summary of Significant Accounting Policies in the notes to the consolidated financial statements included in the Company’s 2024 Form 10-K. Not all significant accounting policies require management to make difficult, subjective or complex judgments. However, the policy noted below could be deemed to meet the SEC’s definition of a critical accounting estimate.
Allowance for Credit Losses
Management considers the policies related to the allowance for credit losses as the most critical to the financial statement presentation. The total allowance for credit losses includes activity related to allowances calculated in accordance with Accounting Standards Codification 326, Credit Losses . The allowance for credit losses is established through a provision for credit losses charged to current earnings. The amount maintained in the allowance reflects management’s continuing evaluation of the credit losses expected to be recognized over the life of the loans in the Company’s portfolio. The allowance for credit losses on loans is a valuation account that is deducted from the loans' amortized cost basis to present the net amount expected to be collected on the loans. The allowance for credit losses on off-balance sheet financial instruments is recorded in other liabilities on the consolidated balance sheets. For purposes of determining the allowance for credit losses, the loan portfolio is segregated into pools first by portfolio segment and then by past due status or credit grade. Each pool is assigned a loss estimate, reflecting historical loss rates that incorporate probability of default and severity of losses over the estimated remaining life of the loans. Loans that do not share risk characteristics are evaluated on an individual basis and are not included in the collective (pool) evaluation. Management estimates the allowance balance using relevant available information from internal and external sources relating to past events, current conditions and reasonable and supportable forecasts. Modifications to loss estimates are made to incorporate a reasonable and supportable forecast of future losses at the pool level, as well as any necessary qualitative adjustments using a Portfolio Level Qualitative Factor (“PLQF”) and/or a Portfolio Segment Level Qualitative Factor (“SLQF”). A similar process is employed to calculate a reserve assigned to off-balance sheet financial instruments, specifically unfunded loan commitments and letters of credit. Modified loss estimates are assigned based on the balance of the commitments estimated to be outstanding at the time of default. The PLQF and SLQF are utilized to address factors that are not present in historical loss rates and are otherwise unaccounted for in the quantitative process. A reserve is recorded upon origination or purchase of a loan. See “Summary of Credit Loss Experience” above and Note 4 - Loans and Allowance for Credit Losses on Loans in the accompanying notes to the consolidated financial statements included elsewhere in this report for further discussion of the risk factors considered by management in establishing the allowance for credit losses.
Management considers a range of macroeconomic scenarios in connection with the allowance estimation process. Within the various economic scenarios considered as of March 31, 2025, the quantitative estimate of the allowance for credit loss would increase by approximately $132.8 million under sole consideration of the most severe downside scenario. The quoted sensitivity calculation reflects the sensitivity of the modeled allowance estimate to macroeconomic forecast data, but is absent of qualitative overlays and other qualitative adjustments that are part of the quarterly reserving process and does not necessarily reflect the nature and extent of future changes in the allowance for reasons including increases or decreases in qualitative adjustments, changes in the risk profile and size of the portfolio, changes in the severity of the macroeconomic scenario and the range of scenarios under management consideration.
28

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
Market risk represents the potential economic loss on trading and non-trading portfolios and financial instruments due to adverse price movements in markets including interest rates, foreign exchange rates, credit spreads, commodity prices and equity and related implied volatility levels. The Company is subject to market risk primarily through the effect of changes in interest rates on its portfolio of assets held for purposes other than trading and interest rate derivative instruments that are used for managing interest rate risk. In addition, the Company has exposure to market risk through its trading desks that engage in securities, derivatives and foreign exchange transactions to support the capital raising, investing and hedging activities of customers. The Company may manage or reduce market risk through the use of hedging, short sale or other similar transactions intended to reduce market risk to be within tolerance levels designated by the Company’s market risk management strategy. The Company uses Value-at-Risk (“VaR”) as a means to measure, monitor, and limit aggregate market risk on the trading portfolio. VaR is a statistical risk measure estimating potential loss at the 95th percentile based on a one-year history of market risk factors associated with the trading portfolio. VaR provides a consistent cross-asset measure for risk profiles and allows for diversification benefit based on historical correlations across market moves. As of March 31, 2025, the Company’s exposure through its trading desk does not pose a significant market risk to the Company. All statistical models involve a degree of uncertainty and VaR is calculated at a statistical confidence interval of the 95th percentile based on one-year daily historic market moves. Larger economic losses are possible, particularly during stressed macroeconomic and market conditions.
The responsibility for managing market risk rests with the ALCO, which operates under policy guidelines established by the Company’s board of directors. Oversight of the Company’s compliance with the guidelines is the ongoing responsibility of the ALCO, with exceptions reported to the Executive Risk Committee and the board of directors, if necessary, on a quarterly basis.
Interest Rate Risk Management
The Company’s interest rate sensitivity as of March 31, 2025 is illustrated in the following table. The table reflects rate-sensitive positions as of March 31, 2025 and is not necessarily indicative of positions on other dates. The table does not take into account the effect of the Company’s derivatives designated as cash flow hedges. The balances of interest rate sensitive assets and liabilities are presented in the periods in which they next reprice to market rates or mature and are aggregated to show the interest rate sensitivity gap. The mismatch between repricings or maturities within a time period is commonly referred to as the “gap” for that period. A positive gap (asset sensitive), where interest rate sensitive assets exceed interest rate sensitive liabilities, generally will result in the net interest margin increasing in a rising rate environment and decreasing in a falling rate environment. A negative gap (liability sensitive) will generally have the opposite results on the net interest margin. Certain variable rate loans have embedded floors which limit the decline in yield on those loans at times when market interest rates are extraordinarily low. The degree of asset sensitivity, spreads on loans and net interest margin may be reduced until rates increase by an amount sufficient to eliminate the effects of floors. The adverse effect of floors as market rates increase may also be offset by the positive gap, the extent to which rates on deposits and other funding sources lag increasing market rates for loans and changes in composition of funding.
(in thousands) 0-3 months 4-12 months 1-3 years 3+ years Total
Assets
Interest bearing cash and cash equivalents $ 3,600,969 $ $ $ $ 3,600,969
Investment securities(1) 85,307 280,854 85,175 4,079,883 4,531,219
Variable loans 20,900,433 199,378 133,045 204,455 21,437,311
Fixed loans 47,432 57,454 207,732 725,146 1,037,764
Total loans(2) 20,947,865 256,832 340,777 929,601 22,475,075
Total interest sensitive assets $ 24,634,141 $ 537,686 $ 425,952 $ 5,009,484 $ 30,607,263
Liabilities
Interest bearing customer deposits $ 15,781,587 $ $ $ $ 15,781,587
CDs 953,511 1,340,301 99,656 3,199 2,396,667
Total interest bearing deposits 16,735,098 1,340,301 99,656 3,199 18,178,254
Short-term borrowings 750,000 750,000
Long-term debt 113,406 174,783 372,332 660,521
Total borrowings 863,406 174,783 372,332 1,410,521
Total interest sensitive liabilities $ 17,598,504 $ 1,515,084 $ 99,656 $ 375,531 $ 19,588,775
GAP $ 7,035,637 $ (977,398) $ 326,296 $ 4,633,953 $
Cumulative GAP $ 7,035,637 $ 6,058,239 $ 6,384,535 $ 11,018,488 $ 11,018,488
Non-interest bearing deposits 7,874,780
Stockholders’ equity 3,429,774
Total $ 11,304,554
(1) Available-for-sale debt securities, equity securities and trading securities based on fair market value.
(2) Total loans include gross loans held for investment and loans held for sale.
29


While a gap interest table is useful in analyzing interest rate sensitivity, an interest rate sensitivity simulation provides a better illustration of the sensitivity of earnings to changes in interest rates. Earnings are also affected by the effects of changing interest rates on the value of funding derived from non-interest bearing deposits and stockholders’ equity. Management performs a sensitivity analysis to identify interest rate risk exposure on net interest income. Management also quantifies and measures interest rate risk exposure using a model to dynamically simulate the effect of changes in net interest income relative to changes in interest rates over the next twelve months based on different interest rate scenarios. These are a static rate scenario and “shock test” scenarios, as described below.
These scenarios are based on interest rates as of the last day of a reporting period published by independent sources and incorporate relevant spreads of instruments that are actively traded in the open market. The Federal Reserve’s federal funds target affects short-term borrowing; the prime lending rate, SOFR, Bloomberg Short Term Yield Index and other alternative indexes are the basis for most of the variable-rate loan pricing. The 10-year treasury rate is also monitored because of its effect on prepayment speeds for mortgage-backed securities. These are the Company’s primary interest rate exposures. Interest rate derivative contracts may be used to manage exposure to adverse fluctuations in these primary interest rate exposures as is discussed in more detail under the heading Use of Derivatives to Manage Interest Rate and Other Risks below.
For modeling purposes, the “shock test” scenarios as of March 31, 2025 and March 31, 2024 assume immediate parallel, sustained 100 and 200 basis point increases in interest rates as well as 100 and 200 basis point decreases in interest rates. The Company will continue to evaluate these scenarios as interest rates change.
The Company’s interest rate risk exposure model incorporates assumptions regarding the level of interest rate, including indeterminable maturity deposits (non-interest bearing deposits, interest bearing transaction accounts and savings accounts) and loan and security prepayment behaviors for a given level of market rate change. In the current environment of changing short-term rates, deposit pricing can vary by product and customer. These assumptions have been developed through a combination of historical analysis and projection of future expected pricing behavior. Changes in prepayment behavior of mortgage-backed securities and residential and commercial mortgage loans in each rate environment are captured using industry estimates of prepayment speeds for various coupon segments of the portfolio. The impact of these changes is factored into the simulation model results and indicated interest rate sensitivity as follows:
Annualized Hypothetical Change in Net Interest Income
March 31, 2025 March 31, 2024
+ 200 basis points 7.4 % 2.8 %
+ 100 basis points 3.8 % 1.5 %
- 100 basis points (6.1) % (4.5) %
- 200 basis points (12.2) % (9.2) %
The simulations used to manage interest rate risk are based on numerous assumptions regarding the effect of changes in interest rates on the timing and extent of repricing characteristics, future cash flows and customer behavior. These assumptions are inherently uncertain and, as a result, the model cannot precisely estimate net interest income or precisely predict the impact of higher or lower interest rates on net interest income. Actual results will differ from simulated results due to timing, magnitude and frequency of interest rate changes as well as changes in market conditions, customer behavior and management strategies, among other factors.
Use of Derivatives to Manage Interest Rate and Other Risks
In the ordinary course of business, the Company enters into derivative transactions to manage various risks and to accommodate the business requirements of its customers.
On the date the Company enters into a derivative contract, the derivative is designated as either a fair value hedge, cash flow hedge, net investment hedge, or a designation is not made as it is a customer-related transaction, an economic hedge for asset/liability risk management purposes or another stand-alone derivative created through the Company’s operations.
To manage the sensitivity of earnings and capital to interest rate, prepayment, credit, price and foreign currency fluctuations (asset and liability management positions), the Company may enter into derivative transactions. In addition, the Company enters into interest rate and foreign exchange derivative contracts to support the business requirements of its customers (customer-related positions).
For additional information regarding derivatives, see Note 10 - Derivative Financial Instruments in the accompanying notes to the consolidated financial statements included elsewhere in this report.
30

ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
The Company’s management, with the supervision and participation of its Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based upon that evaluation, the Company has concluded that, as of the end of such period, its disclosure controls and procedures were effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed in the reports that the Company files or submits under the Exchange Act and were effective in ensuring that information required to be disclosed in the reports filed or submitted under the Exchange Act is accumulated and communicated to the Company's management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There were no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(e) and 15d-15(f) under the Exchange Act) during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
31

PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
The Company is subject to various claims and legal actions that may arise in the ordinary course of conducting its business. Management does not expect the disposition of any of these matters to have a material adverse impact on the Company’s financial statements or results of operations.
ITEM 1A. RISK FACTORS
There have been no material changes in the risk factors previously disclosed in the 2024 Form 10-K.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The Company repurchased shares of its common stock in the open market during the three months ended March 31, 2025 as follows:
Total Number of Approximate Dollar Value
Shares Purchased as Part of Shares That May Yet
Total Number of Average Price Paid of Publicly Announced Be Purchased Under the
Shares Purchased
per Share(1)
Plans or Programs(2)
Plans or Programs(1)(2)
First Quarter
January 2025 152,757 $ 78.48 152,757 $ 188,012,300
February 2025 160,757 80.94 160,757 175,000,085
March 2025 82,592 72.60 82,592 169,003,778
Total 396,106 $ 78.25 396,106 $ 169,003,778
(1)    The approximate dollar value of shares that may yet be purchased under the plans or programs and average price paid per share do not include the effect of excise tax expense incurred on net stock repurchases.
(2)    On January 22, 2025, the Company’s board of directors authorized a new share repurchase program under which the Company may repurchase up to $200.0 million in shares of its outstanding common stock, excluding the effect of excise tax expense incurred on net stock repurchases. Any repurchases under the repurchase program will be made in accordance with applicable securities laws from time to time in open market or private transactions. The extent to which the Company repurchases shares, and the timing of such repurchases, will be at management’s discretion and will depend upon a variety of factors, including market conditions, the Company’s capital position and amount of retained earnings, regulatory requirements and other considerations. The share repurchase program is set to expire on January 31, 2026, and the program may be suspended or discontinued at any time. Remaining repurchase authorization under the January 17, 2024 share repurchase program was terminated upon authorization of this new program.
32


ITEM 6. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
(a) Exhibits

10.1
10.2
31.1
31.2
32.1
32.2
101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH XBRL Taxonomy Extension Schema Document*
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB XBRL Taxonomy Extension Label Linkbase Document*
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document*
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
*    Filed herewith
**    Furnished herewith
+    Management contract or compensatory plan arrangement


33

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
TEXAS CAPITAL BANCSHARES, INC.
Date: April 17, 2025
/s/ J. Matthew Scurlock
J. Matthew Scurlock
Chief Financial Officer
(Duly authorized officer and principal financial officer)
34
TABLE OF CONTENTS